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2.1 BACKGROUND AND AIM OF THE STUDY 
 
Ischemia-reperfusion injury (IRI), which is unavoidable in liver transplantation, is a multifactorial 
process that can cause non-function or dysfunction of the graft (Bilzer,M. et al., 2000a, Clavien,P.A. et 
al., 1992b, Jaeschke,H., 1996). These complications are the major cause for retransplantation and 
mortality. An understanding of the mechanisms involved in IRI is essential for the design of therapeutic 
strategies to prevent IRI and thus improve the outcome of liver transplantation. 
In recent years, the Atrial Natriuretic Peptide (ANP) has been demonstrated to posses potential in 
protection against IRI (Bilzer,M. et al., 1994d, Carini,R. et al., 2003b, Cottart,C.H. et al., 2003a, 
Gerbes,A.L. et al., 1998e, Sangawa,K. et al., 2004, Vollmar,A.M. et al., 2001). Nevertheless, many 
questions remain to be answered about signaling pathways involved in ANP-mediated effects and the 
processes responsible for its protective properties. 
The isolated perfused rat liver is a well-investigated model for examination of treatment-mediated 
effects during ischemia and reperfusion (IR) in the liver (Bilzer,M. et al., 1994c, Bilzer,M. et al., 2000b, 
Gerwig,T. et al., 2003h). Using this setting, Kiemer et al. demonstrated that ANP-preconditioning 
increases the activity of p38 MAPK (Kiemer,A.K. et al., 2002l) in isolated perfused livers during IR. 
Functional consequences of an activation of p38 MAPK are widely unknown. This protein kinase has 
been shown to participate in the regulation of cytoskeletal structures in various cells (Landry,J. et al., 
1995b). Thus, our field of interest was to find a causal connection between ANP-mediated effects and 
possible cytoskeletal changes during IR in this model. In respect of IRI in the liver, ANP was 
evidenced to exhibit protective effects also in vivo (Cottart,C.H. et al., 2003b), but so far nothing is 
known about signaling pathways responsible for this action. Apototic cell death in the liver during IR is 
discussed controversial (Gujral,J.S. et al., 2001c, Kohli,V. et al., 1999d, Rosser,B.G. et al., 1995a) and 
ANP was demonstrated to mediate anti-apoptotic effects in the isolated perfuse rat liver (Gerwig,T. et 
al., 2003g, Kulhanek-Heinze,S. et al., 2004c). We therefore aimed to determine whether ANP 
mediates effects in the liver in vivo regarding apoptotic death during IR. 
ANP has not only been shown to have protective properties in IRI but also anti-inflammatory effects in 
vitro (Tozawa,Y. et al., 2002c, Vollmar,A.M. et al., 2001). In previous studies we were able to show 
that ANP prevents TNF-α production in murine macrophages and whole human blood after LPS-
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stimulation (Kiemer,A.K. et al., 2000a). Moreover, we demonstrated that ANP also inhibits TNF-α-
induced activation of NF-κB in human endothelial cells and reduces LPS-induced TNF-α secretion in 
Kupffer cells (KC) (Kiemer,A.K. et al., 2002w, Kiemer,A.K. et al., 2002a). With regard to inflammatory 
processes during LPS-induced endotoxemia TNF-α has been demonstrated to be one of the 
prototypic pro-inflammatory cytokines mediating many of the immunopathological features of this 
disease (Dinarello,C.A., 1997). During sepsis endogenous ANP is suggested to be a regulatory 
mediator, as the level of its precursor Pro-ANP in blood from septic patients has been demonstrated to 
be an important prognostic marker for the outcome of sepsis (Morgenthaler,N.G. et al., 2005a). 
Another topic discussed in this work is therefore the disease pattern of sepsis. This life-threatening 
disorder results from a harmful host response to infection and is the leading cause of death for 
patients in intensive care units (Angus,D.C. et al., 2001a, Cohen,J., 2002f). Despite intensive research 
on the mechanisms involved in the fatal outcome of this disease, few is known about potential 
therapies preventing death of patients suffering from sepsis. 
 
Based on the knowledge of ANP-mediated protective effects during deleterious processes in IRI and 
its anti-inflammatory properties we therefore aimed to answer the following questions: 
 
1. Does pretreatment with ANP cause cytoskeletal changes in the liver during IR in the isolated 
perfused rat liver? 
Which cell type is affected? 
What are the underlying signaling mechanisms for these changes? 
 
2. Is apoptosis of liver cells during liver transplantation influenced by ANP? 
Which anti-apoptotic pathway is involved? 
 
3. Are anti-inflammatory properties of ANP able to maintain survival after LPS-induced septic 
shock? 
How does ANP influence inflammatory processes during endotoxaemia? 
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2.2 ISCHEMIA/REPERFUSION INJURY (IRI) 
 
 
2.2.1 General aspects 
 
Although substantial progress has been made in surgical techniques, preservation of organs and 
optimization of pretreatment procedures, dysfunction or non-function of the graft after transplantation 
is still a severe problem causing complications and mortality after liver transplantation. IRI causes up 
to 10 % of early organ failure and can lead to acute and chronic rejection in transplanted patients 
(Fellstrom,B. et al., 1998, Howard,T.K. et al., 1990). Consequently, minimizing the damaging effects of 
IRI could significantly increase the number of patients that may undergo a successful liver 
transplantation. For this reason it is important to understand the mechanisms underlying IRI in order to 
design therapeutic strategies.  
IRI in the liver can be divided into two phases: First, deprivation of oxygen during ischemia activates 
deleterious processes in the cells. The resulting damage is even amplified in the second phase, the 
following restoration of oxygen supply during reperfusion (Carini,R. et al., 2003a). 
Hypoxic conditions occurring during ischemia lead to a disruption of the mitochondrial respiratory 
chain followed by depletion of ATP and breakdown of energy metabolism in the cell (Nishimura,Y. et 
al., 1998, Paxian,M. et al., 2003a). Consequences of ATP deprivation are the disturbance of ion 
homoeostasis, an increase in intracellular calcium, and an activation of calcium dependent proteases, 
which in turn cleave proteins essential for cellular survival and function (Kohli,V. et al., 1999b, 
Sindram,D. et al., 1999).  
During reperfusion, when oxygen supply of the tissue is restored, the formation of reactive oxygen 
species (ROS) plays a crucial role (Teoh,N.C. et al., 2003a). ROS are released by Kupffer cells (KC), 
the resident liver macrophages, which are rapidly activated after early reperfusion and contribute to 
tissue damage due to activation of proteases, nitric oxide synthases, phospholipases and 
endonucleases, which in turn are responsible for oxidation of cellular lipids, cytoskeleton disruption, 
membrane damage, and DNA degradation. ROS are therefore suggested to act as direct cytotoxin to 
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epithelial cells (EC) and hepatocytes (Bilzer,M. et al., 1999b, Clavien,P.A. et al., 1992a). 
KC also produce pro-inflammatory mediators including TNF-α, interleukins, platelet-activating factor 
(PAF), and chemokines attracting neutrophiles to migrate to the injured tissue. In a vicious circle, 
interleukins further promote the production of ROS, the release of TNF-α stimulates KC to produce 
even more TNF-α, and attraction of ROS releasing neutrophiles causes an additional increase in ROS 
levels and, moreover, disturbances in microcirculation. These disturbances again induce vascular 
congestion, edema, and further infiltration of inflammatory cells (for review see (Selzner,N. et al., 
2003, Teoh,N.C. et al., 2003b)). IRI is therefore characterized by inflammatory processes, 
deterioration of cell structure and disturbances of microcirculation in the affected tissue – events that 
cause death of hepatic cells subsequently leading to loss of function of the organ. 
 
 
2.2.2 Tissue damage and IRI: apoptosis or necrosis? 
 
The relevance of apoptotic versus necrotic cell death in ischemia/reperfusion is still controversial. 
When liver cells are irreversibly damaged during ischemia they can undergo necrotic or apoptotic cell 
death, whereas the switch to the respective kind of cell death is suggested to depend on the severity 
of the death-inducing stimulus. Thus, moderate hypoxia may induce apoptosis and severe hypoxia 
may induce necrosis (Kaplowitz,N., 2000). Nevertheless, some groups consider apoptosis the major 
type of cell death during IR: Several studies demonstrate that 50-70 % of endothelial cells and 40-60 
% of hepatocytes undergo apoptosis during reperfusion (Gao,W. et al., 1998a, Kohli,V. et al., 1999c, 
Rudiger,H.A. et al., 2003). Moreover, inhibition of apoptotic cell death, for example by treatment with 
caspase inhibitors (Cursio,R. et al., 1999c, Natori,S. et al., 2003), suppression of expression of pro-
apoptotic genes via small interference RNA (Contreras,J.L. et al., 2004a), or overexpression of anti-
apoptotic genes (Bilbao,G. et al., 1999, Selzner,M. et al., 2002) prevents cell death and improves 
survival after prolonged periods of ischemia.  
However, the results of other groups indicating hepatocellular necrosis to be responsible for IRI 
yielded a controversy over the past years about the type of cell death occurring during reperfusion 
(Clavien,P.A. et al., 2001, Gujral,J.S. et al., 2001b, Jaeschke,H. et al., 2004a, Redaelli,C.A. et al., 
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2002, Teoh,N.C. et al., 2003c). 
A possible solution of this conflict might be the presence of both types of cell death during reperfusion, 
which was described by Lemasters et al. as “necrapoptosis” (Lemasters,J.J., 1999). The author 
suggests that necrosis and apoptosis can be induced by the same stimulus, with the progression to 
one of theses forms of cell death depending on the presence or absence of ATP. In this context the 
onset of mitochondrial permeability transition (MPT) which is followed by mitochondrial uncoupling and 
ATP depletion plays the key role in electing the necrotic or apoptotic pathway. On the one hand, ATP 
depletion after MPT onset has been demonstrated to cause necrotic cell death (Qian,T. et al., 1997). 
On the other hand, it leads to mitochondrial swelling followed by release of cytochrome c, activation of 
the caspase cascade, and subsequent apoptotic cell death (Liu,X. et al., 1996). This theory is 
confirmed by data of other groups demonstrating that in case of a prevention of ATP-depletion 
necrotic cell death does not occur (Leist,M. et al., 1997, Nicotera,P. et al., 1999, Paxian,M. et al., 
2003b). 
With respect to IRI in the liver, ANP pretreatment has been shown to cause prevention of apoptosis 
and necrosis ex vivo (Gerwig,T. et al., 2003f). Therefore, aim of the study was to investigate the in 
vivo effect of ANP on apoptosis during liver transplantation and its signaling pathway during orthotopic 
rat liver transplantation.  
 
 
 
2.3 ROLE OF THE PI3-KINASE PATHWAY IN APOPTOTIC CELL 
DEATH 
 
2.3.1 Apoptosis and necrosis 
 
Apoptosis is a highly regulated process, which was first described by Kerr et al. in 1972 and is 
responsible for elimination of excess cells during development and damaged cells during regular 
tissue turnover (Kerr,J.F. et al., 1972b). It is characterized morphologically by chromatin condensation, 
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nucleosomal DNA degradation, cell shrinkage, and blebbing of the plasma membrane, which results in 
the separation of the cell into small vesicles called “apoptotic bodies” (Kerr,J.F. et al., 1972a, 
Walker,N.I. et al., 1988). Structural alterations of the cell surface ensure that apoptotic bodies are 
recognized and phagocytized either by macrophages or parenchymal cells and subsequently 
degraded within lysosomes (Duvall,E. et al., 1985). Degradation of apoptotic cells is a result of 
activation of caspases and endonucleases, which induce cleavage of structural proteins, repair 
enzymes, and DNA. Caspases, which represent a family of cystein-dependent aspartate-specific 
proteases, play a crucial role in the progression of apoptosis (Nicholson,D.W. et al., 1997). They are 
expressed constitutively as inactive proenzymes composed of an N-terminal prodomain and two 
subunits, and are activated through proteolytic cleavage of the zymogen. Apoptotic cell death is mostly 
limited to a single cell or a small group of cells antagonising inflammatory processes by maintenance 
of an intact plasma membrane, thus preventing the release of potentially inflammatory cell content 
(Walker,N.I. et al., 1988). However, previous findings suggest that apoptotic cell death can be equally 
effective as necrosis in inducing hepatic inflammation by triggering neutrophil accumulation in the liver 
tissue (Faouzi,S. et al., 2001, Jaeschke,H., 2002, Yin,X.M. et al., 2003b). 
In contrast to apoptosis, necrosis is a passive, barely regulated process occurring in response to a 
variety of harmful conditions and cytotoxic substances, such as hyperthermia, cellular trauma, 
metabolic poisons, etc.. This from of cell death is characterized by cell swelling and lysis, and typically 
induces local inflammation by release of cytoplasmatic components, which in turn attract phagocytes 
(Raffray,M. et al., 1997, Walker,N.I. et al., 1988). 
As demonstrated in various studies, dysregulation of apoptosis pathways in the liver contributes to 
diseases like hepatocellular carcinoma, viral hepatitis, autoimmune hepatitis, ischaemia-reperfusion 
injury, toxic liver damage and acute liver failure (Jaeschke,H. et al., 2004b, Nakamoto,Y. et al., 2003, 
Yin,X.M. et al., 2003a). Therefore, it is essential to find new strategies for a successful intervention in 
apoptotic pathways for protection against tissue damage in the liver. The influence of ANP on 
apoptotic signaling in the liver is thus an attractive target for investigation of protective strategies 
against IRI. 
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2.3.2 Involvement of PI3-kinase in anti-apoptotic signaling 
 
2.3.2.1 PI3-kinases 
 
Phosphatidylinositol 3-kinases are heterodimers composed of a catalytic subunit (p110) and a 
regulatory subunit (p85), the latter being activated by receptors with protein tyrosine kinase activity as 
well as by G-protein-coupled receptors (Datta,S.R. et al., 1999f, Osaki,M. et al., 2004a). They are 
characterized by their ability to phosphorylate inositol ring 3`-OH groups in inositol phospholipids. 
Binding of the ligand (for example growth factors such as IGF-1) to its receptor results in association 
of the SH-domain of PI3-K with the receptor, followed by allosteric activation of the catalytic subunit of 
PI3-K (figure 1). Consequently, active PI3-K causes immediate generation of the second messenger 
PIP3 (phosphatidylinositol-3,4,5-triphosphate), which is responsible for recruitment of other signaling 
proteins containing a pleckstrin homology (PH)-domain to the plasma membrane. 
 
2.3.2.2 Akt kinase 
 
The 57 kDa serine/threonine kinase Akt, also termed PKB due to sequence homologies with PKA and 
PKC, is the cellular homologue of the transforming oncogene of AKT8 onciovirus (Datta,S.R. et al., 
1999e, Scheid,M.P. et al., 2001). To date, three members of the Akt family have been identified, 
namely Akt1, Akt2, and Akt3 (PKB α,β,γ), which are closely related to each other, with up to 80 % of 
amino acid homology. The amino-terminus of each Akt isoform contains a PH-domain, while its kinase 
domain is similar to that of PKA and PKC. As described in 2.3.2.1, PIP3 recruits proteins with PH-
domains to the plasma membrane, thus causing translocation of Akt towards the membrane (figure 
1). This translocation brings Akt into proximity with other PH-domain-containing enzymes such as 
PDK-1 (3-phosphoinositide-dependent kinase 1). PDK-1 then phosphorylates Akt at threonine 308 in 
the activation loop, thereby enabling binding of ATP to its substrates. For full kinase activation, 
additional phosphorylation at serin 473 is necessary, but the kinase responsible, termed PDK-2, has 
not been identified yet. Possible candidates are PDK-1, the protein kinase ILK (integrin-linked kinase), 
and Akt itself (Brazil,D.P. et al., 2001, Persad,S. et al., 2001, Toker,A. et al., 2000). 
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2.3.2.3 Bad 
 
Bad is a member of the family of Bcl-2 proteins functioning as an apoptosis-regulating factor 
(Chao,D.T. et al., 1998, Downward,J., 2004c). Several members of the Bcl-family promote survival 
(including Bcl-2, Bcl-XL, BAG, A1, MCL-1), while others induce apoptotic cell death (including Bad, 
Bcl-Xs, Bax, Bak). In viable cells anti-apoptotic proteins are localized in membranes such as the outer 
mitochondrial membrane, the endoplasmic reticulum, and the nuclear membrane, anchored through 
an additional carboxy-terminal hydrophobic domain. The pro-apoptotic proteins, in contrast, are mainly 
found in the cytosol (Krajewski,S. et al., 1993, Wolter,K.G. et al., 1997). Interaction of the proteins and 
formation of homo- and heterodimers play a crucial role in prevention or activation of apoptotic 
processes (Datta,S.R. et al., 1999d). Thus, Bad in its unphosphorylated form binds and inactivates 
anti-apoptotic proteins such as Bcl-2 or Bcl-XL leading to proapoptotic effects (figure 1). 
Phosphorylation of Bad at either of the two potential sites (Ser112, Ser136) causes Bad to dissociate 
from Bcl-2 or Bcl-XL, respectively, and to associate instead with the cytoplasmic 14-3-3 proteins 
preventing Bad from dephosphorylation and subsequently promoting cell survival. 
Three kinases have been suggested to phosphorylate Bad at three different residues: Erk 1/2 and 
PKA phosphorylate Bad at Ser 112, Akt at Ser 136, while PKA is additionally able to phosphorylate 
Bad at Ser 155 (Downward,J., 2004b). 
Various studies report an essential role of Bad as a downstream target of Akt in anti-apoptotic effects 
of this kinase. For example, Akt promotes survival of neurons via phosphorylation of Bad at Ser 136 
(Datta,S.R. et al., 1997b). Moreover, it has been shown in different tumor cells that Akt inhibits 
apoptosis by phosphorylating Bad (Datta,S.R. et al., 1997a, del Peso,L. et al., 1997, Fernando,R.I. et 
al., 2004). Akt also phosphorylates Bad at Ser136 in vivo and mutation of Bad Ser 136 to alanine 
abrogates the blocking effect of Akt in Bad-induced apoptosis (Datta,S.R. et al., 1999c). 
In summary, all these studies demonstrate that Bad plays a key role in the Akt survival signaling. 
However, due to the lack of knowledge about signaling pathways regarding prevention of apoptosis of 
liver cells after IR, aim of the present study was to elucidate a possible participation of the PI3-kinase 
pathway and thus Akt-dependent phosphorylation of Bad during this insult. 
 
 
2 Introduction 
 
 
15
kinase
PHp85
p110
P
Bad
extracellular
plasma membrane
intracellular
Receptor
Protein thyrosin
kinase
Growth factors, 
insulin, etc.
P
PIP2
P P P
PIP3
PI3-kinase
Akt inactive
PDK1
PDK2
P
P P P
PIP3
kinase
PH
P Akt active
Bcl-2/Bcl-XL
Apoptosis
Bcl-2/Bcl-X
L
Bad
P Ser
136
14-3-3
survival
Bad
P Ser
136
14-3-3
Bad
kinase
kinase
kinase
kinase
kinase
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
figure 1: Mechanisms of Bad inactivation via the PI3-kinase pathway 
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2.4 HEAT SHOCK PROTEINS AND CYTOSKELETON 
 
2.4.1 Heat shock proteins 
 
Stress or heat shock proteins (Hsp) were first discovered in 1962 as a set of highly conserved proteins 
with cytoprotective properties, whose expression was induced by different kinds of cellular stress 
(Ritossa,F., 1996). These proteins were shown to be ubiquitous and abundant in nearly all cellular 
compartments with their expression and activation dependent on stimuli contributing to cellular stress, 
like heat shock, oxygen deprivation, ROS, cytokines, etc.. According to their molecular weight they are 
divided into four major families: Hsp90, Hsp70, Hsp60, and the small Hsp (Hsp27 and α-crystallin) 
(Georgopoulos,C. et al., 1993). Hsp function – mostly in an energy-dependent manner - as so called 
“molecular chaperones” with responsibility for the import of proteins into cellular compartments, folding 
of proteins, degradation of unstable proteins, resolution of protein complexes, refolding of misfolded 
proteins, and control of regulatory proteins (Santoro,M.G., 2000). Induction of Hsp in response to 
stress correlates with increased resistance of the cells to subsequent damage. The stress-induced 
transcription requires the activation of a transcription factor , namely heat shock factor (HSF), which 
then binds to the heat shock responsive element (HRE) on the DNA, whereas the high specificity of 
each heat shock protein results from multiple HSFs and a cell type specific allocation of Hsp 
(Morimoto,R.I., 1998). Previous studies have shown that the induction of the heat shock response 
requires the activation and translocation of Hsp to the nucleus (Ellis,S. et al., 2000, Ohgitani,E. et al., 
1999).  
A characteristic feature of small Hsp, namely Hsp27 (which corresponds to Hsp25 in mouse and rat) 
and α-chrystallin, is their oligomerization of unphosphorylated monomers to large protein aggregates 
(>500 kDa) (MacRae,T.H., 2000). Hsp27, an ATP-independent chaperone, which was first isolated 
and described by Miron et al. 1988 (Miron,T. et al., 1988), facilitates the refolding of partial 
denaturated proteins into active conformations in vitro (Jakob,U. et al., 1993). Moreover, it can act as 
a regulator of actin polymerization (Benndorf,R. et al., 1994d). It has been shown in previous studies 
in vitro and in vivo that expression of Hsp27 is in accordance to DNA-binding activity of HSF (Ito,H. et 
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al., 1996, Kato,K. et al., 1998). To date four differents HSFs have been identified and recently, HSF-1 
was demonstrated to be responsible for activation of Hsp27 mediated effects in renal cells (Riordan,M. 
et al., 2004). 
 
2.4.2 Influence of Hsp27 on cytoskeletal structures 
 
Post-translational regulation of Hsp27 via phosphorylation is essential for cytoprotective properties of 
the heat shock protein (Landry,J. et al., 1995a, Lavoie,J.N. et al., 1995). In respective studies a 
nonphosphorylatable form of Hsp27 was used in Chinese hamster cell lines, which were no longer 
resistant against heat shock, showed higher sensitivity against cellular stress, and exhibited a 
significant deceleration in regeneration of cytoskeletal structures. The latter observation, indicating a 
regulation of actin dynamics actually is the most important function of Hsp27, and has therefore been 
investigated intensively in various systems (Aufricht,C. et al., 1998b, Dalle-Donne,I. et al., 2001, 
Gomes,M.D. et al., 2003, Panasenko,O.O. et al., 2003). 
Prior studies on the interaction of Hsp27 and cytoskeletal proteins demonstrate that, in its 
unphosphorylated form, Hsp27 inhibits the polymerization of actin by binding to the capping end of 
actin filaments, thus preventing actin monomers (G-actin) from binding to actin filaments (F-actin) 
(Benndorf,R. et al., 1994c, Wieske,M. et al., 2001). Moreover, Miron et al. demonstrated that 
unphosphorylated Hsp27 contributes to the depolymerization of filamentous (F-) actin into monomeric 
G-actin in vitro (Miron,T. et al., 1991). 
However, when phosphorylated, Hsp27 dissociates from actin filaments, thereby inducing the 
conversion of G-actin into actin filaments (Arrigo,A.P. et al., 1994). The phosphorylation of the heat 
shock protein is regulated via the MAPK-signaling cascade. Phosphorylation at Ser 82 and Ser 15, 
promoting the dissociation of Hsp27 multimers, is achieved by activation of p38 MAPK and 
subsequent phosphorylation of MAPKAPK-2, which in turn directly phosphorylates Hsp27 (Lambert,H. 
et al., 1999, Landry,J. et al., 1995c). This activation pathway of the heat shock protein has been 
described in different cells and organ systems, but has as yet been unknown in the liver 
(Freshney,N.W. et al., 1994b, Murashov,A.K. et al., 2001b, Nakano,A. et al., 2000a). The function of 
Hsp27 as a cytoprotective mediator of cytoskeletal stabilization has been thoroughly investigated in 
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the heart, suggesting an involvement of the heat shock protein in cardioprotection after ischemic 
preconditioning in vitro and in vivo (Cohen,M.V. et al., 2000, Sakamoto,K. et al., 2000c, Sanada,S. et 
al., 2001e). 
Sakamoto et al. additionally demonstrated that in rat hearts ischemia induces translocation of Hsp27 
to the cytoskeleton (Sakamoto,K. et al., 2000b), and Aufricht et al. showed the same effect in rat 
kidneys (Aufricht,C. et al., 1998a). This reallocation of Hsp27 accompanied by cytoskeletal changes 
was also observed in pancreas tissue of rats (Schäfer,C. et al., 2000), cardiomyocytes of rabbits 
(Armstrong,S.C. et al., 1999), and human keratinocytes (Wong,J.W. et al., 2000), therefore suggesting 
an interaction of Hsp27 with the cytoskeleton to be important for its regulatory function in actin 
polymerization. 
 
2.4.3 Actin polymerization 
 
Actin filaments are dynamic structures which undergo permanent reconstruction. This persistent 
assembly and disassembly is very important for their functional role inside the organism. Representing 
5 % of total cellular protein, actin is available in the cell in equal shares as monomeric form (G-actin) in 
the cytosol and filamentous chains (F-actin) in the cytoskeleton and cellular membranes. F-actin is 
composed of two strands of actin polymers, which are twisted in a helical structure. As shown in 
figure 2, the polymerization of actin is an energy-dependent process.  
 
 
 
 
 
 
 
 
 
figure 2: Schematic illustration of actin polymerization (see text for details) 
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Monomeric actin binds to adenosine-triphosphate (ATP), which is hydrolyzed to adenosine-
diphosphate (ADP) immediately after attachment of G-actin monomers to the actin filament. Vice 
versa, as soon as ATP binds to the complex and replaces ADP, which is important for stabilization of 
the F-actin strand, actin depolymerization occurs, leading to separation of G-actin monomers 
(Kuhn,T.B. et al., 2000b). 
The balance of intracellular F- and G-actin is regulated by actin binding proteins, which are divided 
into two classes, depending on their regulatory function (McGough,A., 1998): monomer binding 
proteins, for example thymosine, are responsible for retention of G-actin in the cytosol of cells and 
instant allocation of actin monomers when actin polymerization is necessary for reparation or 
stabilization of cellular structures. The second class of actin binding proteins can attach to polymeric 
structures like F-actin, thus influencing polymerization, but also crosslinking of F-actin chains. The 
actin depolymerizing factor (ADF) is one example for such a regulator protein (Kuhn,T.B. et al., 
2000a). Following dephosphorylation of ADF, this actin binding protein enhances the F-actin turnover 
by increasing actin depolymerization and cleaving filaments. The capping proteins also belong to the 
second class of actin binding proteins (Landry,J. et al., 1995d). This proteins bind to the “capping end” 
of actin filaments and prevent the attachment of additional actin monomers. A representative of these 
proteins is Hsp27, which regulates F-actin polymerization by means of occupying the G-actin binding 
end of actin filaments, thus inhibiting polymerization (see 2.4.2). 
In the liver actin filaments are present predominantly in the plasma membrane of hepatocytes and 
sinusoidal cells (Song,J.Y. et al., 1996a). They are responsible for maintenance of cell morphology, 
intracellular transport processes, exo- and endocytosis, and canalicular motility responsible for bile 
flow (Denk,H. et al., 1986, Fisher,M.M. et al., 1979, Marceau,N. et al., 2001). In addition cytoskeletal 
structures are important to ensure stability and mobility of liver cells and play an important role in the 
regulation of store-operated calcium-channels (SOCs), and in the organization of the endoplasmic 
reticulum and tight junctions (Marceau,N. et al., 2001, Song,J.Y. et al., 1996c, Wang,Y.J. et al., 2002a) 
(Arias I.M., 2001b). 
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2.5 THE ATRIAL NATRIURETIC PEPTIDE 
 
 
Atrial natriuretic peptide (ANP) is a peptide hormone, which was first described in 1981 by De Bold et 
al. (de Bold,A.J. et al., 1981). Besides ANP, more natriuretic peptides have been discovered: brain 
natriuretic peptide (BNP), C-type natriuretic peptide (CNP) and dendroaspis natriuretic peptide (DNP) 
(Levin,E.R. et al., 1998a, Richards,A.M. et al., 2002). This year, Fry et al. even found three additional 
natriuretic peptides in the venom of the Australian snake Oxyuranus microlepidotus, which are 
structurally different from ANP/BNP, but have not been further characterized yet (Fry,B.G. et al., 
2005).  
ANP, with its circular structure composed of 28 amino acids (see figure 3), is generated by cleavage 
of its precursor hormone pro-ANP, which has to be released by previous cleavage of Pre-pro-ANP 
(Suttner,S.W. et al., 2004a, Vesely,D.L., 2003). The structure of ANP (see figure 3) shows a ring of 17 
amino acids which is characteristic for natriuretic peptides, with a disulfide linkage between two 
cystein residues being essential for biological activity (Currie,M.G. et al., 1984). 
 
 
 
 
 
 
 
 
 
 
 
figure 3: Structure of ANP  
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ANP is secreted predominantly by cardiomyocytes upon atrial distension caused by volume 
expansion, occurring for example in congestive heart failure and kidney disease, and has been 
described to possess natriuretic, diuretic and vasorelaxant properties (for review see (Suttner,S.W. et 
al., 2004b)). 
BNP is particularly released by ventricular myocardial cells, while CNP is primarily expressed in the 
central nervous system and in vascular endothelium (Levin,E.R. et al., 1998b). With respect to 
biological functions of natriuretic peptides, CNP has been suggested to be a local vascular regulator. 
ANP and BNP have an important function in the regulation of blood pressure and volume homeostasis 
by balancing the renin-angiotensin-aldosterone system, thus exhibiting natriuretic and also diuretic 
effects predominantly in the kidney. Moreover, ANP has been demonstrated to protect against IRI  and 
to have anti-inflammatory effects (Carini,R. et al., 2003d, Vollmar,A.M. et al., 2001). 
 
 
2.5.1 Receptors and signaling mechanisms 
 
Natriuretic peptides (NP) mediate their effects via interaction with the NP receptor (NPR), with three 
different types identified to date (Misono,K.S., 2002, Tremblay,J. et al., 2002). 
The NPR-A receptor binds ANP with a higher affinity than BNP, whereas CNP exerts its properties via 
NPR-B. Both receptors possess an intracellular kinase-like domain and a catalytic guanylyl cyclase 
domain, which is activated after binding of NPs to the receptor, and in turn increases the intracellular 
level of cyclic guanosine monophosphate (cGMP) (see figure 4). The third NPR, however, is 
structurally different, as it does not contain a guanylyl cyclase domain and only a short intracellular 
domain. NPR-C functions as a clearance receptor responsible for removing excessive NPs from the 
bloodstream. Moreover, this receptor is suggested to mediate inhibition of adenylyl cyclase activity, to 
cause activation of phospholipase C, and to be responsible for ANP-mediated inhibition of COX-2 
expression in LPS-stimulated macrophages (Hu,R.M. et al., 1992, Kiemer,A.K. et al., 2002m, 
Palaparti,A. et al., 2000). 
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figure 4:  Natriuretic peptide receptors (NPR) and their ligands.  
 
 
Various studies on knockout mice lacking NPR-A proved that this receptor is essential for ANP-
mediated effects (Melo,L.G. et al., 2000, Pandey,K.N. et al., 1999). With regard to IRI in the liver, the 
protective properties of ANP depend on cGMP-mediated signaling pathways, as the cGMP-analogue 
8-Bromo-cGMP exactly mimicked ANP-induced effects. 
cGMP exerts its regulatory functions by interaction with several cGMP receptor proteins. It has been 
demonstrated that cGMP-dependent protein kinases (PKG) are responsible for mediation of cGMP 
dependent actions in different cell types (Lohmann,S.M. et al., 1997, Pfeifer,A. et al., 1999). 
Interestingly, in higher concentrations, cGMP is also able to activate cAMP-dependent protein kinases 
(PKA) (Cornwell,T.L. et al., 1994). Another possibility for interaction of cGMP with the cAMP signaling 
pathway is via binding to specific phosphodiesterases (PDE), thus stimulating (PDE type II) or 
inhibiting (PDE III) the degradation of cAMP (Lincoln,T.M. et al., 1993). Moreover, in heart and 
kidneys, cGMP has been shown to regulate a cGMP-gated ion channel, therefore contributing to 
natriuretic effects in these tissues (Biel,M. et al., 1998). 
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2.5.2 Effects ANP during IR and inflammatory processes 
 
2.5.2.1 ANP and IRI 
 
Besides its vasodilating, hypotensive, and natriuretic activities (Kourie,J.I. et al., 1999b, Kourie,J.I. et 
al., 1999a, Vesely,D.L., 2001), ANP has been described to protect against IRI ex vivo in the liver and 
in the (Bilzer,M. et al., 1994b, Carini,R. et al., 2003e, Gerbes,A.L. et al., 1998d, Kiemer,A.K. et al., 
2002f), and protective effects in the liver have even been demonstrated in vivo (Cottart,C.H. et al., 
2003c). Perfusion of livers with ANP prior to ischemia and reperfusion markedly reduced cell 
damaged, apoptosis in hepatocytes, necrosis in hepatocytes and endothelial cell, and furthermore 
improved bile flow (Bilzer,M. et al., 1994a, Gerwig,T. et al., 2003e). 
Investigation of underlying signaling mechanisms suggested that ANP mediates its hepatoprotective 
actions via reduced activation of the redox sensitive transcription factors NF-κB and AP-1 resulting in 
decreased expression of the cytokine TNF-α (Kiemer,A.K. et al., 2000k, Kiemer,A.K. et al., 2000l). 
Moreover, Bilzer et al. demonstrated an influence of ANP on Kupffer cell (KC) mediated injury of liver 
tissue. Their results showed that ANP was able to protect liver cells against oxidative stress of 
activated Kupffer cells without influencing superoxide formation of KC (Bilzer,M. et al., 1999a). 
Furthermore, ANP activates the heat shock transcription factor (HSF) paralleled by an increase of 
protein levels of the heat shock protein Hsp70 (Kiemer,A.K. et al., 2002e), which is not only discussed 
to grant thermotolerance, but also to protect against ROS-induced damage and IRI (Becker,J. et al., 
1994, Terajima,H. et al., 2000). As demonstrated by Kiemer et al., ANP increases the activity of p38 
mitogen activated kinase (MAPK) in the liver (Kiemer,A.K. et al., 2002k). This MAPK is suggested to 
possess protective properties in the liver and heart after IR (Sanada,S. et al., 2001d, Schauer,R.J. et 
al., 2003, Teoh,N. et al., 2002). 
Taken together, ANP seems to mediate its protective effects in the liver by either directly preventing 
the production of mediators of cell damage or by improvement of the cellular resistance to cytotoxic 
products. In order to evaluate the potential of ANP as a new pharmaceutical agent mediating 
protective effects during IR, the influence of ANP on signaling pathways involved in IRI of the liver in 
vivo were further investigated. 
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2.5.2.2 ANP and inflammation  
 
ANP has been demonstrated to possess cytoprotective actions in various cells and organs besides the 
liver. A growing body of evidence describes the ability of ANP to prevent LPS-induced inflammatory 
processes. In macrophages, ANP has been shown to inhibit the LPS-mediated induction of inducible 
nitric-oxide synthase (iNOS), therefore preventing the formation of NO, an important mediator of 
inflammation (Kiemer,A.K. et al., 1997b, Kiemer,A.K. et al., 1998a, Kiemer,A.K. et al., 2001). 
Moreover, treatment of macrophages with ANP causes inhibition of LPS-induced cyclo-oxygenase-2 
(COX-2) and decreases TNF-α production after treatment with LPS (Kiemer,A.K. et al., 2000b, 
Kiemer,A.K. et al., 2002p, Tsukagoshi,H. et al., 2001b). 
Besides these in vitro observations, inhibition of the ANP receptor binding involved inflammation in 
vivo in rats with serotonin (5-HT2A) receptor- mediated acute hemodynamic changes (Tozawa,Y. et al., 
2002b), also pointing to anti-inflammatory properties of ANP. Furthermore, ANP increased 
phagocytosis in LPS-stimulated KCs in combination with deceleration of TNF-α release by the liver 
macrophages (Kiemer,A.K. et al., 2002b). In bovine pulmonary microvascular and macrovascular 
endothelial cells stimulated with TNF-α or bacterial endotoxin (LPS), ANP treatment inhibited NF-
kappaB activation and TNF-α synthesis, thus preventing inflammatory processes (Irwin,D.C. et al., 
2005b). This anti-inflammatory effect of the peptide was also demonstrated in human umbilical vein 
endothelial cells (HUVEC), as ANP prevented TNF-α induced NF-κB activity and expression of 
monocyte chemoattractant protein-1 (MCP-1) (Kiemer,A.K. et al., 2002v, Weber,N.C. et al., 2003b). 
Finally, ANP has also an important function in regulating the plasma volume during endotoxemia 
(Qu,X.W. et al., 1998a), and the ANP precursor Pro-ANP is even suggested as a prognostic marker in 
septic patients (Morgenthaler,N.G. et al., 2005b), emphasizing ANP as a potential protective 
endogenous mediator in sepsis. To date, however, there are no data explaining the signaling 
mechanism responsible for ANP-mediated effects during endotoxemia. 
In summary, the anti-inflammatory potential of ANP is of high interest making ANP a major target of 
subsequent studies (for review see (Fürst,R. et al., 2005a, Fürst,R. et al., 2005b, Kiemer,A.K. et al., 
2005, Vollmar,A.M. et al., 2001). 
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2.6 SEPSIS 
 
2.6.1 General aspects 
 
Sepsis, a life-threatening disorder that arises from the body’s response to infection, is the leading 
cause of death for patients in an intensive care unit, with its overall mortality of 30-50 % exceeding 
that of almost all common cancers (Angus,D.C. et al., 2001b, Cohen,J., 2002e).  
The first characterization of this deadly disease reaches back to 1879 when Louis Pasteur for the first 
time showed bacteria to be present in blood from patients suffering from “puerperal septicaemia”. The 
“concept of endotoxin-induced shock and death” was then described in 1894 by Pfeiffer. However, a 
definition of sepsis was reached only in 1992 (American College of Chest Physicians/Society of 
Critical Care Medicine Consensus Conference, 1992): “Sepsis is the response of the host to microbial 
infection with evidence of systemic inflammation, consisting of two or more of the following: increased 
or decreased temperature or leukocyte count, tachycardia, and rapid breathing. Septic shock is sepsis 
with hypotension that persists after resuscitation with intravenous fluid.”  
During sepsis the most common site of infection are the lungs, abdominal cavity, urinary tract, and 
primary infections of the bloodstream. This infection is initiated by gram-negative bacteria in 25-30 % 
of septic patients. Gram-positive and polymicrobial infections account for 30-50 % and 25 % of cases, 
respectively (Annane,D. et al., 2005b). 
As septic patients ultimately die from multiple organ failure, which in early stages of endotoxemia 
develops from failure of a single organ, maintenance of organ function is an important target of 
investigation. The kidney is one of the affected organs during endotoxemia (Cohen,J., 2002g, 
Guijarro,C. et al., 2001a). Due to the knowledge about ANP influencing functional parameters of the 
kidney during endotoxic shock in rats (Aiura,K. et al., 1995b), aim of the present study was to 
elucidate potential anti-inflammatory effects of ANP during endotoxemia in this organ. 
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2.6.2 Pathogenetic networks in sepsis 
 
The pathogenetic network of cellular events causing organ dysfunction in patients suffering from 
sepsis is very complex and has therefore not been completely elucidated. An important effect 
occurring during endotoxemia is the activation of coagulant pathways (Cohen,J., 2002b). Following an 
infection with LPS or other microbial components, the expression of tissue factor (TF) on endothelial 
cells is induced. TF in turn activates proteolytic cascades, followed by formation of thrombin, which 
then generates fibrin from fibrinogen. Simultaneously, levels of plasminogen activator inhibitor-1 (PAI-
1) are increased resulting in disruption of fibrinolyis (figure 5). Subsequently, increased production of 
fibrin causes inadequate tissue perfusion and organ failure due to aggregation of fibrin clots in small 
vessels. This coagulant effect is amplified by concomitant downregulation of anti-coagulant proteins 
such as antithrombin, protein C, and tissue factor pathway inhibitor (Okajima,K., 2001). 
Besides this activation of blood coagulation, the release of pro-inflammatory mediators such as TNF-α 
and IL-1 by endothelial cells, neutrophils, and monocytes increases the production of NO by inducing 
the expression of iNOS. Consequently, NO provokes further vascular instability, cellular dysoxia by 
inhibition of the mitochondrial respiratory chain, in combination with disruption of epithelial tight 
junctions (Annane,D. et al., 2005c). The release of ROS, TNF-α, interferon γ, and high mobility group 
box 1 (HMGB1) from macrophages also contributes to loss of function of the endothelial structure 
causing further instabilization of the vascular system (Woltmann,A. et al., 1998). Activation of the 
complement system, increased expression of adhesion molecules on neutrophils, and subsequent 
migration of activated leucocytes from the bloodstream into inflammatory tissue leads to additional 
deleterious effects on organ function (Holub,M. et al., 2003). In addition, a significant increase in 
lymphocyte apoptosis has been observed in septic patients, consequently provoking an increased 
susceptibility to hospital-acquired infection (Hotchkiss,R.S. et al., 1999, Hotchkiss,R.S. et al., 2001). In 
summary these detrimental events occurring during endotoxemia culminate in coagulopathy, fever, 
vasodilatation, and capillary leak finally causing multiple organ failure and death of patients (see 
schema in figure 5). 
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figure 5: The pathogenetic network during sepsis (see text for details). LPS: Lipopolysaccharide,  
LTA: lipoteichoic acid, PG: peptidoglycan, TF: tissue factor, PAI: plasminogen-activator-inhibitor 
 
The major problem in successful treatment of sepsis is the complexity of challenge and the enormity of 
problems inside the organism of patients once the challenge has been successfully addressed. 
Indeed, two new therapies have made it to market, namely Drotecogin (recombinant human activated 
protein C) (Bernard,G.R. et al., 2001) and low doses of hydrocortisone (Annane,D. et al., 2002), but 
theses treatments are only effective in the early management of septic shock. Moreover, promising 
strategies such as inhibition of mediators of the inflammatory cascade (for example TNF-α, interleukin 
1, platelet activating factor, or NO synthase) failed to improve survival of patients (Marshall,J.C., 
2003). Therefore, it does not astonish that to date a reliable, successful treatment of septic patients is 
an unrealized request. 
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2.6.3 Toll-like receptors 
 
In both, insects and vertebrates, the rapid response to pathogens is called innate immunity. In 
Drosophila the protein Toll is responsible for recognition of pathogens and activation of the innate 
immune response (Lemaitre,B. et al., 1996). In 1997 Medzhitov et al. found the human homologue of 
this protein, which is a type I transmembrane protein with an extracellular domain consisting of a 
leucine-rich repeat (LRR) domain and a cytoplasmic domain homologous to the cytoplasmic domain of 
the human interleukin (IL)-1 receptor (Medzhitov,R. et al., 1997a). This observation gave rise to 
extensive investigation of this protein, and up to now, ten members of the Toll like receptor (TLR) 
family have been defined (Cohen,J., 2002a). The ligands of TLRs are incompletely identified, and are 
apparently not limited to microorganisms, but rather to stimuli that might generally be perceived as 
danger for the host. Examples for TLR ligands from microorganisms are peptidoglycan from Gram-
positive bacteria and bacterial lipoprotein from Gram-negative bacteria, both recognized by TLR2. 
TLR5 binds flagellin from bacterial flagella, whereas TLR9 binds to conserved motifs in bacterial DNA 
(Yamamoto,M. et al., 2004a). Important for endotoxemia induced by lipopolysaccharide (LPS), an 
endotoxin from the cell-wall of Gram-negative bacteria, was the observation of Poltorak et al. in 1998 
(Poltorak,A. et al., 1998). They showed that mutation in the gene encoding for TLR4 in mice causes 
defects in LPS-signaling. Thus, they identified TLR4 as the receptor responsible for LPS-mediated 
signaling.  
The engagement of TLRs on macrophages, neutrophiles, and endothelial cells activates multiple 
signal transduction cascades that lead to alterations in gene expression, particularly nuclear factor κB 
(NF-κB) dependent gene expression (Yamamoto,M. et al., 2004b). This transcription factor is crucially 
involved in pro-inflammatory cytokine expression (see 2.6.4). Subsequently, the generated 
inflammatory mediators can act on the cell in an autocrine fashion, on neighbouring cells in a 
paracrine, and on distant tissues in an endocrine manner, evoking new signaling cascades, all 
together being responsible for the consequences of infection in the organism (Beutler,B., 2004). 
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2.6.4 Signaling pathways during LPS-induced sepsis 
 
After infection of the host, LPS is carried in the blood by a specific carrier protein, namely 
Lipopolysaccharide-binding protein (LBP) (Cohen,J., 2002c). This interaction causes monomerization 
of LPS, thus transforming it into the bioactive formation (Schromm,A.B. et al., 1996). Through the 
surface-bound CD14 receptor the endotoxin interacts with cells of the innate immune system 
(Wright,S.D. et al., 1990) (see schema figure 6). As previously shown, CD14 is not only present as 
membrane-bound receptor, but also in a soluble form in the circulation (Cohen,J., 2002d). The 
endotoxin-CD14 complex then engages the LPS-specific receptor TLR4 (2.6.3) and thus initiates 
intracellular signaling. For activation of TLR4, the cell-surface molecule MD-2 is essential, which is 
suggested to be responsible for correct positioning of the receptor on the cell surface (Shimazu,R. et 
al., 1999, Yang,H. et al., 2000). 
Each TLR possesses its own TIR (Toll/IL-1 receptor/resistance motif) domain responsible for 
interaction with adaptor proteins such as the myeloid differentiation protein MyD88 in case of TLR4. 
These adaptors have been demonstrated to be crucial for the cellular response to LPS-binding 
(Kawai,T. et al., 1999, Zhang,F.X. et al., 1999a). In addition to MyD88, subsequent elements recruited 
to the TLR4 activation complex are the IL-1 receptor associated kinase (IRAK) and TNF-α receptor-
associated factor (TRAF6) (Medzhitov,R. et al., 1997b, Medzhitov,R. et al., 1998). The essential role 
of IRAK and TRAF-6 has been demonstrated in mutants in vitro and in knock-out studies in vivo 
(Cao,Z. et al., 1996, Lomaga,M.A. et al., 1999, Zhang,F.X. et al., 1999b). However, the mechanism by 
which TRAF6 activates the IκB kinase (IKK) complex downstream in the course of LPS-mediated 
signaling is not understood yet. IKKα and IKKβ form the IKK complex together with IKKγ (also named 
NEMO for NF-κB essential modulator) (DiDonato,J.A. et al., 1997, Rothwarf,D.M. et al., 1998). Upon 
phosphorylation, IKK rapidly phosphorylates its downstream target, the NF-κB inhibitor proteins IkB at 
two phosphorylation sites (Ser 32 and Ser 36 in IκBα) (Whiteside,S.T. et al., 1997). Once 
phosphorylated, IκBs undergo polyubiquitination by a specialized E3 ubiquitin ligase complex known 
as E3 IκB(DiDonato,J. et al., 1996, Winston,J.T. et al., 1999, Yaron,A. et al., 1998). Polyubiquitinated 
IκBs are then targeted for rapid degradation by the S26 proteasome, thus releasing NF-κB and 
facilitating translocation of the transcription factor into the nucleus (Karin,M. et al., 2000). The NF-κB 
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family so far consists of five identified members: p65 (also named RelA), RelB, c-Rel, p50/p105, and 
p52/p100. In unstimulated cells these proteins exist in homo- or heterodimers in the cytosol, 
inactivated through binding to their inhibitor IκB (Chen,L.F. et al., 2004b). The classical NF-κB 
heterodimer, which is p50/p65, is predominately regulated by IκBα (Beg,A.A. et al., 1995b, 
Klement,J.F. et al., 1996a). After secession of phosphorylated IκB, NF-κB with its two subunits is able 
to migrate from the cytosol into the nucleus, where it binds to the DNA. Subsequently, the activation of 
transcription of NF-κB target genes is induced and even further enhanced via direct acetylation of 
histones, which surround these genes, by the p65 subunit of NF-κB (Chen,L. et al., 2001). Among the 
target genes of NF-κB are those encoding for TNF-α, IL-1, and also IκBα, thus displaying not only a 
starting point of inflammatory processes, but also a negative regulatory response to NF-κB activation 
(Brown,K. et al., 1993, Sun,S.C. et al., 1993). 
Ultimately, the binding of LPS to TLR4 provokes immense production of inflammatory cytokines, which 
are then released into the circulation by the LPS-responding cells.  
Note: In this study only the LPS-mediated effects on NF-κB activation are further investigated  
(figure 6). Besides this signaling cascade infection with LPS might also lead to the activation of MAPK 
pathways causing for example activation of the activator protein-1 (AP-1) transcription factors, jun and 
fos (Irie,T. et al., 2000, Ninomiya-Tsuji,J. et al., 1999), but this signaling pathway is not further 
specified in this work. 
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figure 6: Signaling pathways leading to NF-κB activation during LPS-induced sepsis.  
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3.1 THE ISOLATED PERFUSED RAT LIVER 
 
3.1.1 Animals 
Male Sprague-Dawley rats (weight range: 200-300 g) were purchased from Charles River Wiga GmbH 
(Sulzfeld, Germany) and housed in a climatized room with a 12 h light-dark cycle. The animals had free 
access to chow (Ssniff, Soest, Germany) and water and received human care. All studies were performed 
with the permission of the government authorities and in accordance with the German Legislation on 
Laboratory Animal Experiments. 
 
 
3.1.2 Materials and solutions 
3.1.2.1 Materials 
Atrial Natriuretic Peptide (ANP, rat), SB203580 (SB), and Wortmannin (WM) were purchased from 
Calbiochem/Novabiochem (Bad Soden, Germany). Narcoren® was from Merial GmbH (Halbergmoos, 
Germany). All other materials were purchased from either Sigma (Deisenhofen, Germany) or VWR 
International™ (Munich, Germany). 
 
3.1.2.2 Solutions 
Krebs-Henseleit buffer (KH buffer) pH 7.4 
NaCl   118 mM 
KCl   4.8 mM 
KH2PO4  1.2 mM  
MgSO4    1.2 mM 
CaCl2   1.5 mM 
NaHCO3  25 mM 
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3.1.3 Experimental setting 
 
Liver perfusion was performed by Dr. Tobias Gerwig (Department of Pharmacy, University of Munich, 
Munich, Germany). 
As described by Gerbes et al. (Gerbes,A.L. et al., 1998c), male Sprague-Dawley rats were anaesthetized 
with Pentobarbital (Narcoren®, 50 mg/kg body weight, intraperitoneally), 250 IU heparin were 
administered, the portal vein was cannulated, and the liver was perfused in situ with hemoglobin- and 
albumin-free bicarbonate buffered Krebs-Henseleit (KH) solution (pH 7.4, 37 °C) gassed with 95% O2 and 
5% CO2. The perfusion medium was pumped through the liver at a constant flow rate in a non-
recirculating manner. 
 
 
 
 
 
 
 
 
 
figure 7: Isolated liver perfusion: Livers were perfused with KH buffer before ischemia for 30 min either in the 
absence or in the presence of 200 nM ANP, ±SB (2 µM) given 20 min prior to ischemia. Livers were 
kept under ischemic conditions for 24 h in University of Wisconsin solution (UW solution) and 
reperfusion for 45 min. Organs were excised and snap-frozen at the indicated times (n=6 animals in 
each treatment group). 
 
 
After 10 min of perfusion with KH buffer, ANP (200 nM) was added to the perfusion buffer (depending on 
the treatment group), followed by an additional perfusion for 20 min. When indicated, SB was added to 
the KH buffer followed by 30 min of perfusion (figure 7). 
Subsequently, livers were perfused with 30 ml of cold (4 °C) University of Wisconsin (UW) solution 
(DuPont Pharma GmbH, Bad Homburg, Germany) for 1 min and stored in UW solution for 24 h at 4 °C 
under ischemic conditions. 
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Following ischemia, livers were reperfused with KH solution for up to 45 min. The graft’s common bile 
duct was cannulated with a PE-tube and bile was collected and its volume determined. Bile flow was 
calculated per min and g liver tissue. At the indicated times (after 30 min perfusion, 24 h ischemia, 45 min 
reperfusion), livers were snap-frozen in liquid nitrogen and stored at -85 °C until further examination (see 
also figure 7). All experiments were performed with n=6 animals for each treatment group. 
 
 
3.1.4 Homogenization and fractionation of liver tissue for Western 
Blot analysis 
 
A fractionation protocol was employed according to published methods with some modifications 
(Carey,D.J. et al., 1987a, Carey,D.J. et al., 1987b, Fox,J.E. et al., 1992). Briefly, 50 mg of liver tissue 
were homogenized in 1.5 ml of lysis buffer (50 mM Tris-HCl pH 7.0, 5 mM EGTA, 1 mM PMSF, 1 mM 
Na3VO4, 40 µl Complete®) containing 1% Triton® X-100 (Roth, Karlsruhe, Germany) with a dounce 
homogenizer. After centrifugation at 15,000xg (15 min, 4 °C) the cytoskeletal fraction remained in the 
pellet. Supernatants, representing the cytosolic fraction, were cleared by ultracentrifugation (100,000xg, 
2.5 h, 4 °C). The pellet was resuspended in SDS-containing sample buffer and the cytosolic fraction was 
diluted with the same sample buffer. Samples were stored at –20 °C until use for Western Blot analysis.  
 
 
3.1.5 Quantification of actin content in liver fractions 
 
After detection of F- and G-actin in liver samples by Western Blot analysis, the densitometric intensity of 
the corresponding bands was used to evaluate the ratio of F-, and G-actin respectively to total actin  
(F- + G-actin) in the corresponding sample. 
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3.2 RAT LIVER TRANSPLANTATION 
 
3.2.1 Animals 
 
Syngeneic, male Lewis rats (donors: 207±12 g; recipients: 276±18 g) were purchased from Charles River 
Wiga (Sulzfeld, Germany) and housed in a temperature- and humidity-controlled room under a constant 
12 h light/dark cycle. Animals had free access to water and chow (Ssniff, Soest, Germany), but were 
fasted with free access to water 12 h prior to the operation. All studies were performed with the 
permission of the government authorities and in accordance with the German Legislation on Laboratory 
Animal Experiments.  
 
 
3.2.2 Materials and solutions  
 
Materials and solutions used for in vivo experiments are described in chapter 3.1.2. 
 
 
3.2.3 Experimental setting 
 
In vivo experiments with ANP were performed by Dr. Uwe Grützner (Institute for Surgical Research, 
Klinikum Großhadern, University of Munich, Germany). 
In transplantation experiments donor animals obtained a 20 min intravenous infusion of either 0.9 % NaCl 
or ANP (5 µg/kg b.w.) prior to hepatectomy. For investigation of signaling pathways additional rats were 
treated with Wortmannin (WM, 16 µg/kg b.w., in 0.1 % DMSO), DMSO (0.1%), or a combination of ANP 
and WM (see figure 8). 
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figure 8: ANP pretreatment in vivo: Rats received an intravenous infusion of 0.9 % NaCl, ANP (200 nM), 
Wortmannin (16 µg/kg b.w.), or various combinations for 20 min. The liver was excised, kept for 24 
h under ischemic conditions, transplanted into recipient, and reperfused for up to 2 h. Livers were 
excised at the indicated time points, snap-frozen, and stored at -85 °C until further investigation. 
 
 
Donor and recipient operations were performed under ether anesthesia after premedication with atropine 
(0.1 mg/kg b.w.). Blood pressure and heart rate were continuously monitored by a catheter in the carotid 
artery. A jugular catheter was used to apply substances and substitute plasma volume. Body temperature 
was kept between 36.5 °C and 37.5 °C by means of a heating pad. Donor livers were preserved by 
retrograde aortal flush with 10 ml UW-solution and stored at 4 °C for 24 h. Prior to implantation, the livers 
were rinsed with 10 ml of cold Ringer’s solution (B. Braun Medical Inc., Irvine, CA, USA) via the portal 
vein at a hydrostatic pressure of 10 cm H2O. 
Orthotopic liver transplantation was performed using a modified cuff technique as described (Schauer,R.J. 
et al., 2004). Grafted livers were simultaneously reperfused after completion of the arterial anastomosis. 
Portal clamping time was less than 20 min in all experiments. 
The graft’s common bile duct was cannulated with a PE-tube and bile was collected and its volume 
determined. The bile flow was calculated per min and g liver tissue. Plasma samples (400 µl) were 
obtained from the recipient before hepatectomy as well as 60 and 120 min after reperfusion of the 
transplanted liver. The removed blood volume was replaced by saline. After starting reperfusion, rats 
received 1.0 ml of albumine (5%) and 0.5 – 1.0 ml sodium bicarbonate solution to maintain blood 
pressure and physiological pH. To avoid fluid loss and drying of the liver, the abdominal cavity was 
covered with Saran wrap. 
After 20 min preconditioning, 24 h cold ischemia, or 120 min reperfusion, a small section of each organ 
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was placed in 4% paraformaldehyde and embedded in paraffin wax for TUNEL staining. The remaining 
organ was snap frozen in liquid nitrogen and stored at -85 °C until further analysis  
(figure 8). All experiments were performed using n=4 animals for each treatment group. 
 
 
3.2.4 Determination of activities of serum aminotransferases and 
lactate dehydrogenase 
 
Activities of serum aminotransferases (alanine transferase (ALT), aspartate transferase (AST)) and LDH 
were determined as established markers of hepatic injury. Activities were measured by Dr. Uwe Grützner 
(Institute for Surgical Research, Klinikum Großhadern, University of Munich, Germany) 2 h after 
reperfusion using a serum multiple analyzer (Olympus AU 2700, Germany) at 37 °C. 
 
 
3.2.5 PKA activity assay 
 
This assay was performed with a commercial PKA assay kit obtained from Calbiochem. Tissue samples 
(100 µg) were homogenized in ice-cold “extraction buffer” and centrifuged as described in the 
manufacturer’s manual. Supernatants were used for measurement of PKA activity by in vitro 
phosphorylation of the specific peptide substrate kemptide with [γ32P]-ATP. 
 
 
3.2.6 Caspase-3-like activity assay 
 
Caspase activity was measured by applying a synthetic peptide substrate which is coupled to a 
fluorophor. Cleavage of the fluorogenic substrate by the activated caspase leads to increased 
fluorescence.  
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After homogenization of 100 mg liver tissue in 1 ml of lysis buffer (25 mM HEPES, 5 mM MgCl2, 1 mM 
EGTA (pH 7.5), Complete®), samples were centrifuged at 14,000 rpm (10 min, 4 °C). In the supernatants, 
caspase-3-like activity was determined as reported previously (Gerwig,T. et al., 2003c, Gerwig,T. et al., 
2003d). Briefly, generation of free fluorescent 7-amino-4-trifluoro-methylcoumarin (AFC) from the 
substrate DEVD-AFC (Sigma, Deisenhofen, Germany) was measured after incubation at 37 °C with a 
microplate reader (Spectra Fluor Plus, TECAN Deutschland GmbH, Crailsheim, Germany). Protein 
concentrations were determined by Pierce Assay (Pierce,R.H. et al., 2000) (Pierce, Rockford, USA). 
Control experiments revealed the linear character of activity regarding duration and protein concentration. 
Thus, specific caspase-3-like activity was calculated per µg protein. 
 
 
 
3.3 MURINE MODEL OF LPS-INDUCED SEPSIS 
 
3.3.1 Animals 
 
Specific pathogen-free male BALB/c mice (22±6 g) were supplied by the in house Animal Breeding 
Facility of the University of Konstanz and housed in a temperature- and humidity-controlled room  
(22 °C, 55% humidity) under a constant 12 h light/dark cycle. Animals had free access to water and chow 
(Ssniff, Soest, Germany), but were fasted with free access to water 12 h prior to the in vivo experiment. 
All studies were performed with the permission of the government authorities and in accordance with the 
German Legislation on Laboratory Animal Experiments and followed the directives of the University of 
Konstanz Ethical Committee.  
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3.3.2 Materials and solutions  
 
3.3.2.1 Materials 
 
Rat ANP was purchased from Calbiochem/Novabiochem (Bad Soden, Germany), Lipopolysaccharide 
(LPS) from Salmonella abortus equi S. from BIOCLOT (Aidenbach, Germany). Pentobarbital (Nembutal), 
which was used for anesthesia of animals, was from Sanofi-Ceva (Hanover, Germany). TNF-α enzyme-
linked immunosorbent assay (ELISA) was purchased from Amersham Bioscience (Braunschweig, 
Germany). All other materials were purchased from either Sigma (Deisenhofen, Germany) or VWR 
International™ (Munich, Germany). 
 
3.3.2.2 Solutions 
 
ANP and LPS were diluted in a total volume of 300 µl sterile 0.9 % saline solution containing 0.1% human 
serum albumine (HSA). 
 
 
3.3.3 Experimental setting  
 
ANP (5 µg/kg b.w.) was injected intravenously (i.v.). Septic shock was induced by intraperitoneal (i.p.) 
injection of a sublethal LPS dose of 1 mg/kg b.w. for the 90 min experiments, and a lethal dose of 2.5 
mg/kg b.w. for survival experiments 20 min after ANP treatment (figure 9). 
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figure 9:  Experimental setting for ANP preconditioning in vivo before LPS-induced septic shock. Animals 
were injected i.v. with ANP (5 µg/kg b.w.) or NaCl and after 20 min with LPS or NaCl i.p.. After 90 
min blood samples were taken and used for determination of TNF-α level. LPS was injected in a 
sublethal (1 mg/kg b.w.) or lethal (2.5 mg/kg b.w.) dose. Survival of animals was observed until up 
to 72 h after LPS injection. For sample generation, organs were excised at indicated times (20 min 
after ANP injection t = 0 min, after LPS injection at t = 15 min, t = 30 min, and t = 90 min) after lethal 
intravenous anesthesia. For measurement of TNF-α concentration, blood samples were generated 
after 90 min. 
 
 
3.3.3.1 Survival experiment (72 h) 
 
To investigate whether ANP preconditioning has an effect on survival after injection of a lethal LPS dose, 
ANP (5 µg/kg b.w.) was injected i.v. 20 min prior to i.p. LPS-injection (2.5 mg/kg b.w. in 300 µl saline 
containing 0.1% HSA). After LPS-injection the animals’ state of health was observed continuously for 72 
h. Animals of the control group were injected with 0.9 % NaCl at t = -20 min and t = 0 min. Animals of the 
LPS-group were injected with NaCl instead of ANP at the onset of the survival experiment (see also 
figure 9). 
After 90 min, blood samples for TNF-α measurement were obtained by slightly cutting the animals’ tail 
and collecting approximately 50 µl blood into a heparinized microfuge tube. Blood samples were 
centrifuged (13,000 rpm, 2 min, 4 °C) immediately before TNF-α concentration was determined by ELISA 
(see 3.3.4). 
Four treatment groups were generated, each group with n=8 animals (see table 1). 
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table 1:  Treatment groups for survival experiment.  
 
 
3.3.3.2 Tissue sample generation (endotoxemia) 
 
This in vivo experiment started with the intravenous injection of NaCl or ANP (5 µg/kg b.w.). Animals 
received an i.p. injection of NaCl or LPS (1 mg/kg b.w.) after 20 min. At the indicated times  
(see figure 9), blood and tissue samples were obtained after lethal intravenous anesthesia of mice with 
150 mg/kg b.w. pentobarbital plus 0.8 mg/kg b.w. heparin. 
Blood samples were taken after 90 min following abdominal laparotomy. TNF-α serum concentrations 
were determined. For this purpose, blood was withdrawn by cardiac puncture, filled into heparinized 
microfuge tubes, and centrifuged (2 min, 13,000 rpm, 4 °C). 
Kidneys were excised at t = 0 min, t = 15 min, and t = 90 min, and snap-frozen immediately in liquid 
nitrogen. The latest time point for excision of organs was 90 min. Therefore, this kind of experimental 
setting for investigation of ANP effects on LPS-signaling is termed “endotoxemia”. 
Four treatment groups were generated, each group consisting of n=6 animals (see table 2). 
 
table 2:  Treatment groups for endotoxemia. 
 
Treatment group t = -20 min t = 0 min 
Control (Co) NaCl i.v. NaCl i.p. 
ANP ANP (5 µg/kg b.w.) i.v. NaCl i.p. 
LPS NaCl i.v. LPS (1 mg or 2.5 mg/kg b.w.) i.p. 
ANP/LPS ANP (5 µg/kg b.w.) i.v. LPS (1 mg or 2.5 mg/kg b.w.) i.p. 
Treatment group t = -20 min t = 0 min 
Control (Co) NaCl i.v. NaCl i.p. 
ANP ANP (5 µg/g b.w.) i.v. NaCl i.p. 
LPS NaCl i.v. LPS (1 mg/kg b.w.) i.p. 
ANP/LPS ANP (5µg/kg b.w.) i.v. LPS (1 mg/kg b.w.) i.p. 
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3.3.4 Determination of TNF-α concentrations in blood samples 
 
Blood samples were centrifuged for 2 min at 4 °C at 13,000 rpm to separate the plasma from the cellular 
fraction. Measurement of TNF-α by ELISA was performed as described previously (Bohlinger,I. et al., 
1996) with an OptEIA Mouse TNF-α Elisa Set (Mono/Mono) (BD Biosciences, Heidelberg, Germany). 
Briefly, 50 µl of sample were pipetted onto a microtiter plate which was coated with a mouse specific 
TNF-α antibody. 50 µl of a biotinylated antibody reagent was added, followed by incubation for 2 h at 
room temperature (RT). After several washing steps, 100 µl of a streptavidine-horseradish peroxidase-
conjugate was added. Following incubation for 30 min (RT) and five more washing steps, incubation for 
30 min (RT, protected from light) with 100 µl of the substrate solution TMB (3', 5, 5' - tetramethyl-
benzidine) caused a color development proportional to the amount of mouse TNF-α in the sample. The 
reaction was terminated by addition of 100 µl stop solution (0.18 M sulphuric acid) and optical density was 
determined at 450 nm using the SUNRISE Absorbance Reader from TECAN (TECAN Deutschland 
GmbH, Crailsheim, Germany). 
 
 
3.4 HISTOLOGICAL ANALYSIS OF TISSUE 
 
3.4.1 TUNEL staining 
 
TUNEL staining was kindly performed by Dr. Herbert Meissner and Mrs. Andrea Sendlhofer (Institute of 
Pathology, University of Munich,, Germany). 
Liver samples were fixed in 4% formaldehyde, embedded in paraffin, and cut into 6 µM sections.  Liver 
sections were rinsed three times with PBS (pH 7.4, containing calcium and magnesium), before blocking 
for 20 min with 1% BSA. Apoptotic processes were examined by quantification of DNA fragmentation by 
the terminal deoxynucleotidyl transferase (TdT) mediated dUTP nick end labeling method (TUNEL) as 
described by Gavrieli et al. (Gavrieli,Y. et al., 1992). The number of apoptotic liver cells was determined 
by staining of liver sections with the ApopTaq® Peroxidase in situ Apoptosis Detection Kit according to the 
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manufacturer’s instructions (Intergen, Purchase, New York, USA). For counting the apoptotic cells, an 
area of 1.96 mm2 containing approximately 4,000 hepatocytes was examined by a Zeiss Axiolab 
microscope (Zeiss, Jena, Germany). 
 
 
3.4.2 Hematoxylin staining 
 
Necrotic cell death and morphological changes of tissue were characterized by hematoxylin and eosin 
(HE) staining. Morphological criteria for necrosis included increased eosinophilia, vacuolization, cell 
disruption, loss of architecture, and karyolysis. HE staining was performed by Dr. Herbert Meissner and 
Mrs. Andrea Sendlhofer (Institute of Pathology, University of Munich, Germany). 
 
 
3.4.3 Immunohistochemistry 
 
For analysis of localization and / or presence of certain proteins in liver or kidney, organs were snap-
frozen in liquid nitrogen at the indicated times and cut into 6-10 µm sections. 
For staining of phospho-Akt and F-actin, slices were dried overnight at RT and subsequently fixed in 3% 
formaldehyde for 15 min. For p65 staining, organs were fixed for 3 min in 3% formaldehyde immediately 
after cutting and were kept in PBS. 
Fixed slices of liver or kidney tissue were washed three times with PBS and blocked with 1% BSA for 20 
min. This was followed by incubation with 100 µl of the primary antibody (see table 3) for 1 h at RT. After 
three washing steps, slices were incubated with the corresponding secondary antibody (see  
table 3) for 1 h at RT and again were washed three times with PBS. Finally, liver or kidney sections were 
covered with mounting medium (DakoCytomation GmbH, Hamburg, Germany), dried overnight, and 
examined by confocal microscopy (LSM 510 Meta, Zeiss, Jena, Germany). 
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table 3:  Antibodies used for tissue staining. 
 
 
 
 
3.5 WESTERN BLOT ANALYSIS 
 
3.5.1 Sample preparation – homogenization of tissue 
 
30 mg of kidney or liver tissue were homogenized in 0.6 ml of lysis buffer (50 mM Tris-HCl, 5 mM EGTA, 
1 mM PMSF, 1 mM Na3VO4 pH 7.0, 1x Complete®) containing 1% Triton® X-100 (Roth, Karlsruhe, 
Germany) with a dounce homogenizer. Care was taken to ensure a homogenous suspension. After 
centrifugation of samples at 14,000 rpm (10 min, 4 °C), 10 µl of the supernatant were used for 
determination of protein content (see 3.5.2). The remaining supernatant was diluted with 3x SDS-
Primary antibodies Diluted in Dilution manufacturer 
Mouse anti-phospho-Akt monoclonal 
(Ser 473) 
0.2% BSA 1:200 Cell Signaling, Frankfurt/Main, 
Germany 
Rabbit anti-phospho-Akt polyclonal 
(Ser 473) 
0.2% BSA 1:200 
Cell Signaling, Frankfurt/Main, 
Germany 
Rabbit anti p65 polyclonal 0.2% BSA 1:100 Santa Cruz, Heidelberg, Germany 
Secondary antibodies    
Alexa Fluor® 488 Goat anti-mouse 
IgG 
0.2% BSA 1:400 
Molecular Probes, MoBiTec, Göttingen, 
Germany 
Alexa Fluor® 647 chicken anti-rabbit 
IgG (H+L) 
0.2% BSA 1:400 
Molecular Probes, MoBiTec, Göttingen, 
Germany 
Alexa Fluor® 488 goat anti rabbit IgG 
(H+L) 
0.2% BSA 1:400 
Molecular Probes, MoBiTec, Göttingen, 
Germany 
Rhodamine conjugated phalloidin 
methanol 
p.a. 
1 unit per slice (5 µl stock 
solution 
Molecular Probes, MoBiTec, Göttingen, 
Germany 
HOECHST 33342 dye 0.2% BSA 5 µg per slice Sigma, Deisenhofen, Germany 
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containing sample buffer (see 3.5.4.1) and boiled for 5 min at 95 °C. Aliquots were stored at  
– 80 °C until Western Blot analysis. 
 
 
3.5.2 Measurement of protein concentrations with Pierce assay 
 
In order to employ equal amounts of protein in all samples analyzed by Western Blot, the protein 
concentrations were determined using the Pierce assay (BC assay reagents, Interdim, Montulocon, 
France) as described by Smith et al. (Smith,P.K. et al., 1985). 
 
 
3.5.3 Immunoprecipitation 
 
After homogenization of liver tissue (see 3.5.1) sample protein concentrations were determined by Pierce 
Assay (3.5.2). 100 µg protein in 100 µl lysis buffer were incubated with 2.5 µl of primary antibody (rabbit 
anti Hsp25 or rabbit anti-Bad) shaking overnight at 4 °C. Following centrifugation and resolution of the 
pellet in 500 µl lysis buffer, the antibody-antigen complex was precipitated by incubation with 50 µl of 
washed Agarose-A-beads (Sigma, Deisenhofen, Germany) for 2 h  
(shaking, 4 °C), followed by additional centrifugation. The beads were washed three times with cold lysis 
buffer and resuspended in 40 µl of 3x SDS-containing sample buffer. After addition of 40 µl 1x sample 
buffer, samples were boiled for 5 min at 95 °C followed by centrifugation in order to remove the beads. 35 
µl of the supernatant were used for detection of phospho-Bad by Western Blot analysis. 
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3.5.4 SDS- polyacrylamide gel electrophoresis (SDS-PAGE) 
 
3.5.4.1 Solutions 
 
SDS sample buffer (stock solution)   SDS sample buffer (3x) 
Tris-HCl (pH 6.8) 37.5 ml    Stock solution   950 µl 
SDS   6 g    β-mercaptoethanol  50 µl 
Glycerol  30 ml  
Bromphenol blue 15 mg 
H2O   ad 100 ml  
 
To prepare 1x sample buffer solution, the appropriate amount of water was added to the 3x solution. 
 
Separation gel 10%     Stacking gel 
PAA solution (30%)  5.0 ml   PAA solution (30%)  1.275 ml 
1.5 M Tris-base, pH 8.8  3.75 ml   1.25 M Tris-HCl, pH 6.8  750 µl 
SDS 10%   150 µl   SDS 10%   75 µl 
H2O    6.1 ml   H2O    5.25 ml 
TEMED   15 µl   TEMED   15 µl 
APS 10%   75 µl   APS 10%   75 µl  
 
For preparation of separation gels different concentrations of polyacrylamide (PAA, 30% solution of PAA / 
0.8% bisacrylamide 37.5 : 1 (v/v), Rotiphorese™ Gel 30, Roth, Karlsruhe, Germany) were used according 
to the molecular weight of the analyzed protein.  
 
Electrophoresis buffer (5x ) 
Tris-base   15.0 g  
Glycine    72.0 g 
SDS    5.0 g 
H2O    ad 1,000 ml 
 
To prepare 1x Electrophoresis buffer, the appropriate amount of water was added to the 5x buffer. 
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3.5.4.2 Electrophoresis 
 
Denaturating SDS-PAGE allows the separation of proteins according to their molecular weight. Proteins 
are solubilized in a sodium dodecylsulfate (SDS) solution, a highly negatively charged detergent. After 
denaturation of the proteins by addition of dithiothreitol (DTT) and boiling of samples, negatively charged 
SDS-polypeptide complexes migrate towards the anode. Their migration velocity corresponds to the 
protein’s molecular weight (Laemmli,U.K., 1970). 
Equal amounts of protein (70 µg per slot for IκBα and phospho-IκBα, 100 µg for other proteins) were 
loaded and separated by SDS-PAGE (Mini PROTEAN 3, BioRad Laboratories, Munich, Germany). 
Electrophoresis was run at 100 V for 21 min for stacking, and 4 min at 200 V for separating the proteins. 
 
 
 
3.5.5 Western Blot 
 
3.5.5.1 Solutions 
 
Tris-CAPS (5x), pH 9.6   
Tris-base   36.34 g 
CAPS    44.26 g  
H2O    ad 1,000 ml 
 
 
Anode buffer      Cathode buffer 
Tris-CAPS (5x)   20 ml   Tris-CAPS (5x)   20 ml 
Methanol   15 ml   SDS 10%   1 ml 
H2O    ad 100 ml  H2O    ad 100 ml 
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Tank Blotting buffer (5x)    Tank Blotting buffer (1x) 
Tris-base   15.2 g   Blotting buffer (5x)  200 ml 
Glycine    72.9 g   Methanol   200 ml 
H2O    ad 1,000 ml  H2O    ad 1,000 ml 
 
 
Tris-buffered saline pH 8.0 containing 0.1% Tween (TBS-T) 
Tris-base   3.0 g 
NaCl    11.1 g 
Tween 20   1.0 ml 
H2O    ad 1,000 ml 
 
 
Coomassie staining solution    Coomassie destaining solution   
Coomassie brilliant blue G 1.5 g   Acetic acid (100%)  100 ml  
Acetic acid (100%)  50 ml   Ethanol (96%)   335 ml 
Ethanol (96%)   225 ml   H2O        ad 1,000 ml  
H2O    ad 500 ml  
 
 
ECL solution 
Solution 1:      Solution 2: 
Luminol (250 mM)  50 µl   H2O2 (30 %)   3 µl 
p-Coumaric acid (90 mM) 22 µl   1 M Tris, pH 8.5  500 µl 
1 M Tris, pH 8.5  500 µl   H2O    4,500 µl 
H2O    4,500 µl 
 
 
Stripping buffer 
Tris-HCl   62.5 mM 
SDS    2% 
β-mercaptoethanol  0.8% 
 
 
5% Blotto: 
5% (m/v) solution of low fat dried milk (Blotto, BioRad, Munich, Germany) in TBS-T pH 8.0. 
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Antibodies: 
table 4:  Primary and secondary antibodies used for Western blot analysis. Abbreviations: WB = Western 
Blot analysis, IP = Immunoprecipitation. 
 
 
3.5.5.2 Semi dry Blotting 
 
For the transfer of proteins to a polyvinylidene fluoride (PVDF) membrane by Semi dry Blotting in a 
discontinuous buffer system, we used the Fastblot B43 (Biometra, Göttingen, Germany). The membrane 
Primary antibodies Diluted in Dilution Manufacturer Used for 
Mouse anti-actin 5% Blotto 1:1,000 Biozol, Eching, Germany WB 
Rabbit anti-Akt (tot) 5% BSA 1:1,000 
Cell Signaling, Frankfurt/Main, 
Germany 
WB 
Rabbit anti-phospho-Akt (Ser 473) 1%BSA 1:1,000 
Cell Signaling, Frankfurt/Main, 
Germany 
WB 
Rabbit anti-Bad (tot) 5% BSA 1:1,000 
Cell Signaling, Frankfurt/Main, 
Germany 
WB, IP 
Mouse anti-phospho-Bad (Ser 112) 5% BSA 1:2000 
Cell Signaling, Frankfurt/Main, 
Germany 
WB 
Rabbit anti-phospho-Bad (Ser 136) 1% Blotto 1:500 
Cell Signaling, Frankfurt/Main, 
Germany 
WB 
Rabbit anti-Hsp25 (tot) 5% Blotto 1: 1,000 
Stress Gen Biotechnologies, 
Victoria, Canada 
WB, IP 
Rabbit anti-phospho-Hsp27 (Ser 82) 5% BSA 1:1,000 
Cell Signaling, Frankfurt/Main, 
Germany 
WB 
Rabbit anti IκB-α (tot) 1% Blotto 1:1,000 Santa Cruz Heidelberg, Germany WB 
Rabbit anti-phospho-IκB-α (Ser 32) 1% Blotto 1:1,000 
Cell Signaling, Frankfurt/Main, 
Germany 
WB 
Secondary antibodies     
Goat anti-rabbit IgG (H+L) 
1% Blotto 1:20,000 Dianova, Hamburg, Germany 
WB 
Goat anti mouse IgG1 5% Blotto 1:1,000 Biozol, Eching, Germany WB 
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(Immobilon-P, Millipore, Bedford, MA, USA) was soaked in methanol for 5 min and in anode buffer for 30 
min. Afterwards, proteins were transferred at 134 mA for 60 min from the gel to the membrane. 
 
 
3.5.5.3 Tank Blotting 
 
Proteins were transferred to a nitrocellulose membrane (Hybond™ ECL™, Amersham Bioscience, 
Braunschweig, Germany) at 23 V overnight at 4 °C with a Mini Trans-Blot® (BioRad Laboratories, Munich, 
Germany), and 1x Blotting buffer was used for Tank Blotting (see 3.5.5.1).  
 
 
3.5.5.4 Coomassie blue staining 
 
In order to check the equal loading of samples and correct blotting, the remaining proteins in the gels 
were stained with Coomassie staining solution for 30 min. Afterwards, gels were destained shaking for 60 
min in destaining solution before they finally were stored in water. 
 
 
3.5.5.5 Protein detection 
 
Prior to immunologic detection of the referring proteins, unspecific binding sites were blocked by 
incubating the membrane for 60 min at RT in a 5% (m/v) solution of low fat dried milk (Blotto, BioRad, 
Munich, Germany) in TBS-T pH 8.0. 
Detection of the protein of interest through binding of a specific primary antibody to the protein was 
performed by incubation of the membrane overnight at 4 °C with the appropriate solution of the specific 
primary antibody (see table 4). After four washing steps (4 x 5 min in TBS-T), the membrane was 
incubated with the secondary antibody (conjugated to horseradish peroxidase (HRP), table 4) for 60 min, 
followed by four additional washing steps (2 x 10 min, 2 x 5 min). 
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For detection of proteins, the membrane was incubated in a mixture (1:1) of the two detection solutions, 
solution 1 and solution 2 (see 3.5.5.1) for 1 min. Chemoluminescence detection was performed by 
exposure of the membrane to a medical X-ray film (Fuji, Düsseldorf, Germany) and subsequent 
development with a Curix 60 developing system (Agfa-Gevaert N.V., Mortsel, Belgium). 
Quantification was performed with a Kodak image station (NEN, Cologne, Germany). 
 
3.5.5.6 Reprobing  
 
For removing primary and secondary antibodies from the membrane, blots were incubated in stripping 
buffer (see 3.5.5.1) shaking for 30 min at 50 °C. After six washing steps (5 min in TBS-T at RT), the 
membrane was blocked for 1 h with 5% low fat dried milk (in TBS-T) before detection with another 
primary antibody as described in 3.5.5.5. 
 
 
 
3.6 ELECTROPHORETIC MOBILITY SHIFT ASSAY (EMSA) 
 
3.6.1 Solutions 
 
Buffer A      Buffer B 
HEPES pH 7.9   10 mM   HEPES pH 7.9   20 mM 
KCl    10 mM   NaCl    400 mM 
EDTA    0.1 mM   EDTA    1 mM 
EGTA    0.1 mM   EGTA    0.5 mM 
DTT    1 mM   Glycerol   25% 
PMSF    0.5 mM   DTT    1 mM 
       PMSF    1 mM 
 
DTT and PMSF were added to the Buffer stock solution (A and B) directly before use. 
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STE buffer pH 7.5     5x binding buffer pH 7.5 
Tris-HCl   10 mM   Glycerol   20% 
NaCl    100 mM  MgCl2    5 mM 
EDTA    1 mM   EDTA    2.5 mM 
       NaCl    250 mM 
       Tris-HCl   50 mM 
 
 
Gel loading buffer pH 7.5    reaction buffer 
Tris-HCl   250 mM  DTT    2.6 mM 
Bromphenolblue  0.2%   5x binding buffer  90% 
Glycerol   40%   gel loading buffer  10% 
 
 
10x TBE pH 8.3     non-denaturating polyacrylamide gel (4.5%) 
Tris    0.89 M   10x TBE   5.3% 
Boric acid   0.89 M   PAA solution (30%)  15.8% 
EDTA    0.02 M   glycerol    2.6% 
       TEMED   0.05% 
       APS    0.08% 
 
0.25x TBE was used as electrophoresis buffer and prepared by adding the appropriate amount of water 
to the 10x solution. 
 
 
 
3.6.2 Extraction of nuclear protein 
 
30 mg of kidney tissue were homogenized in 0.3 ml of Buffer A (see 3.6.1) on ice with a dounce 
homogenizer. Care was taken to ensure a homogenous suspension. Samples were centrifuged at 1,000 
rpm at 4 °C for 10 min. The pellet was resuspended in 300 µl Buffer A, followed by addition of 18 µl 
Nonidet-40 (NP-40) and careful mixing of samples. After 10 min incubation on ice, samples were 
centrifuged for 1 min at 14,000 rpm and 4 °C and the pellet was resolved in 40 µl Buffer B. Samples were 
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incubated by shaking for 30 min at 4 °C. After centrifugation (14,000 rpm, 10 min, 4 °C) undiluted 
supernatants were used for EMSA, and diluted 1:20 for determination of protein concentrations. 
 
 
3.6.3 Measurement of protein concentration with Bradford-assay 
 
Protein concentration in isolated nuclear fractions was determined as described by Bradford et al. 
(Bradford,M.M., 1976). 
 
 
3.6.4 Radioactive labeling of consensus oligonucleotides 
 
Double-stranded oligonucleotides, containing the consensus sequence for NF-κB  
(5’-AGTTGAGGGGACTTTCCCAGGC-3’, Promega, Mannheim, Germany), were labeled with  
5’-[γ-32P]triphosphate (3,000 Ci/mmol) by using the T4 polynucleotide kinase (PNK) (USB, Cleveland, 
USA) which catalyzes the transfer of the terminal phosphate of ATP to the 5’-hydroxyl termini of the DNA. 
Oligonucleotides were incubated with PNK for 10 min at 37 °C. The reaction was stopped by addition of 
0.5 M EDTA solution. The radioactive labeled DNA was separated from unlabeled DNA by using NucTrap 
probe purification columns (Stratagene, La Jolla, USA). Radiolabeled DNA was eluated from the column 
with 70 µl of STE buffer and frozen at -20 °C until use for EMSA. 
 
 
3.6.5 Binding reaction and electrophoretic separation 
 
Equal amounts of nuclear protein (approximately 2 µg) were incubated in a total amount of 14 µl 
containing 2 µg poly(dIdC) and 3 µl reaction buffer for 10 min at RT. 1 µl of the labeled oligonucleotide 
probe (approximately 300,000 cpm) was added and incubated with nuclear protein for 30 min at RT. The 
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nucleoprotein-oligonucleotide complexes were separated by gel electrophoresis (Mini-Protean 3, BioRad, 
Munich, Germany) at 110 V for 60 min on non-denaturating polyacrylamide gels (see 3.6.1, 
Rotiphorese™ Gel 30, Roth, Karlsruhe, Germany). Bands were detected by exposure of the gels to 
Cyclone Storage Phosphor Screens (Canberra-Packard, Dreieich, Germany) for about 24 h (time of 
exposure depended on radioactivity of the labeled oligonucleotides), followed by analysis with a 
phosphorimager station (Cyclone Storage Phosphor System, Canberra-Packard, Dreieich, Germany). 
 
 
 
3.7 STATISTICAL ANALYSIS 
 
All experiments were performed at least three times per treatment group (3-8 animals per treatment). 
Data are expressed as mean ± SEM. Statistical significance between groups was determined with one 
sample or student’s t-test using GraphPad Prism® Version 3.03 for Windows (GraphPad Software Inc., 
San Diego, USA). P values < 0.05 were considered statistically significant.
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4.1 EFFECTS OF ANP DURING ISCHEMIA AND REPERFUSION IN 
THE LIVER 
 
 
4.1.1 Effects of ANP preconditioning in the isolated perfused rat liver 
 
4.1.1.1 Participation of p38 MAPK in ANP-mediated cytoskeletal changes during IR 
 
We have shown previously that ANP pretreatment causes an increase in p38 MAPK activity (Kiemer,A.K. 
et al., 2002j) and changes in the hepatic content of cytoskeletal F-actin (diploma thesis). Thus, we were 
now interested in the correlation between p38 MAPK activation and cytoskeletal changes in ANP-
preconditioned livers. For this reason, we used the specific p38 MAPK inhibitor SB203580 (SB). 
Perfusion with 2 µM SB together with ANP completely abolished the enhanced hepatic F-actin content 
after ANP preconditioning (figure 10). 
 
 
 
 
 
 
figure 10: ANP increases F-actin via p38 MAPK. Livers were perfused with KH buffer (Co), ANP (200 
nM), SB (2 µM), or a combination of ANP and SB for 20 min followed by a 24 h period of 
ischemia (3.1.3). Cytoskeletal fractions were investigated by Western Blot. (see 3.1.4 and 
3.5). 
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Similarly, ANP pretreatment caused a decrease of G-actin in liver homogenates (figure 11). This effect 
was abrogated by inhibition of p38 MAPK, so that G-actin content in these samples resembled untreated 
controls. Again, treatment with SB alone had no influence (figure 11). 
 
 
 
 
 
 
figure 11: Liver treatment with a combination of ANP and SB abrogates the ANP-mediated reduction 
of G-actin in livers after 24 h ischemia. After perfusion with KH buffer (Co), ANP (200 nM), 
SB (2 µM), or a combination of ANP and SB for 20 min, livers were kept under ischemic 
conditions (UW solution, 4 °C) for 24 h. Cytosolic fractions were analyzed via Western Blot 
as described (3.1.4 and 3.5). 
 
 
 
Changes in F-actin content mediated by ANP were confirmed by staining of tissue sections. Staining with 
rhodamine-conjugated phalloidin, which specifically binds to F-actin, showed a low fluorescence in tissue 
sections of untreated livers. This correlated with a marginal F-actin content (figure 12 A). Slices of ANP-
pretreated livers showed a very high staining intensity, representing an obvious increase in hepatic F-
actin content. This cytoskeletal changes were observed especially at the membranes of hepatocytes 
(figure 12, B). 
Again, perfusion of the livers with SB alone had no effect on hepatic F-actin (figure 12 C). 
Preconditioning with a combination of SB and ANP however, abolished the ANP-mediated effect (figure 
12 D). This links the observed effect to activation of p38 MAPK. 
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figure 12: ANP increases hepatic F-actin content via p38 MAPK. After perfusion with KH buffer (A), ANP (200 
nM) (B), SB (C), or a combination of ANP and SB (D) for 20 min, livers were excised and kept 
under ischemic conditions (UW solution, 4 °C) for 24 h. Slices of snap-frozen livers were stained 
with Hoechst 33342 for nuclei (blue) and Rhodamine conjugated phalloidin for cytoskeletal F-actin 
(red) (see 3.1.3 and 3.4.3). Liver sections were examined by confocal laser scanning microscopy 
(63-fold amplification). 
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4.1.1.2 Role of p38 MAPK in ANP-mediated phosphorylation of Hsp27 during ischemia 
 
We have previously shown that ANP pretreatment leads to an enhanced activation of p38 MAPK 
(Kiemer,A.K. et al., 2002i) and increases the hepatic content of its downstream target Hsp27. Moreover, 
we demonstrated a translocation of the heat shock protein towards the cytoskeleton after 24 h ischemia 
(diploma thesis). Hsp27 has been described to act as an actin capping protein controlling actin 
polymerization (Landry,J. et al., 1995e), with its function depending on phosphorylation by upstream 
kinases (Benndorf,R. et al., 1994b).  
Based on these results, we were now interested in the phosphorylation status of Hsp27 in untreated and 
ANP-preconditioned livers, and a possible connection between p38 MAPK activation and phosphorylation 
of Hsp27 by employing the p38 MAPK inhibitor SB 203580.  
As shown in figure 13, ANP caused an increase in phosphorylation of the small heat shock protein 
already at 30 min perfusion, and further increasing after 24 h ischemia. 
 
 
 
 
figure 13:  Preconditioning with ANP augments phosphorylation of Hsp27. Following perfusion with KH buffer 
(Co), ANP (200 nM), SB (2 µM), or a combination of ANP and SB for 20 min, livers were kept under 
ischemic conditions (UW solution, 4 °C) for 24 h. Hepatic phospho-Hsp27 was analyzed by 
Western Blot after immunoprecipitation (see 3.1.3 and 3.5). 
 
 
In order to confirm that enhanced phosphorylation of Hsp27 ischemia is mediated via p38 MAPK, we 
perfused the livers with a combination of ANP and SB. In fact, the increase of Hsp27 phosphorylation 
induced by ANP was completely abrogated (figure 14). Pretreatment with SB alone exerted no significant 
effect on phosphorylation of Hsp27. Thus, activation of p38 MAPK is essential for the phosphorylation of 
the heat shock protein induced by ANP. 
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figure 14: Inhibition of p38 MAPK leads to an abrogation of enhanced Hsp27 phosphorylation after ANP 
pretreatment in ischemic livers. Livers were perfused with KH buffer (Co), ANP (200 nM), SB (2 
µM), or a combination of ANP and SB for 20 min. Afterwards, organs were kept under ischemic 
conditions (UW solution, 4 °C) for 24 h, snap-frozen and homogenized as described. Hepatic 
Hsp27 was isolated by immunoprecipitation with a specific anti-Hsp27 antibody. Analysis of 
phospho-Hsp27 (p-Hsp27) levels in the samples by Western Blot was performed as described with 
an anti-phospho-Hsp27 antibody (see 3.1.3 and 3.5 for details).  
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4.1.2 Effects of ANP preconditioning in the liver during IR in vivo 
 
 
4.1.2.1 ANP affects apoptosis in ischemic liver  
 
Apoptotic processes were monitored by measuring caspase-3-like activity and TUNEL staining. After 24 h 
cold ischemia, an increase of hepatic caspase-3-like activity compared to sham operated animals was 
observed. The effect was still detectable after 2 h of reperfusion (125% vs. Co) (figure 15 A). ANP 
pretreatment completely abolished IR-induced caspase activity as shown in figure 15 B. 
 
 
 
 
 
 
 
 
 
 
 
 
figure 15: Hepatic caspase-3-like activity increases during IR (A) but is unaffected in ANP-pretreated 
animals (B). Donor livers were explanted after intravenous infusion of NaCl and kept under 
ischemic conditions (4 °C, UW solution) for 24 h. Livers were transplanted into recipients 
and reperfused for 2 h. At indicated times (after 20 min infusion, 24 h ischemia, and 2 h 
reperfusion), organs were snap-frozen, homogenized and caspase-3-like activity was 
measured as described in “Materials and Methods” with 4 rats in each group. Data are 
expressed as percent of caspase-3-like activity after 20 min infusion of NaCl (Co, A), and 
ANP (B) respectively. * p ≤ 0.05 vs. control after 20 min infusion. 
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Compared to untreated controls, ANP preconditioning caused a significant attenuation of 
caspase-3-like activity, which was most evident in livers after 24 h of cold storage (see figure 16). 
 
 
 
 
 
 
 
 
 
 
 
 
figure 16: ANP preconditioning decreases caspase-3-like activity in the liver after 24 h ischemia. 
Animals received an intravenous infusion of NaCl (Co) or ANP (5 µg/kg b.w.) for 20 min 
and livers were then kept under ischemic conditions (UW solution, 4 °C) for 24 h. Tissue 
was snap-frozen, homogenized, and caspase-3-like activity was determined as described 
(see3.2.6 for details) with 4 animals in each group. Data are expressed as percentage of 
caspase-3-like activity in untreated livers (100%). ** p ≤ 0.01 vs. untreated controls. 
 
 
TUNEL-staining and hematoxylin/eosin (HE) staining of liver sections confirmed the results of caspase-3-
like activity measurement. After 24 h cold ischemia apoptosis was most prominent and accounted for 
about 0.5% of cells. 
Both hepatocytes and endothelial cells showed positive TUNEL staining combined with characteristic 
apoptotic morphology. Preconditioning of donor livers with ANP (5 µg/kg b.w.) significantly decreased the 
number of TUNEL-positive cells after 24 h cold ischemia (see figure 17). A similar effect was observed 
after 2 h of reperfusion, although less pronounced (data not shown)  
Thus, we clearly demonstrated that ANP reduces apoptotic cell death in ischemic liver cells. 
 
 
 
 
4 Results 
 
 
64
∗
Co  ANP  
0
10
20
TU
N
EL
-p
os
iti
ve
 c
el
ls
/fi
el
d
TU
N
EL
-p
os
iti
ve
 c
el
ls
/fi
el
d
 
 
 
 
 
 
 
figure 17: ANP pretreatment reduces the number of apoptotic cells after ischemia in the liver. 
Animals received intravenous infusion of NaCl (Co) or ANP (5 µM) for 20 min. Livers were 
excised, kept under ischemic conditions (UW solution, 4 °C) for 24 h, and embedded in 
paraffin wax before tissue was cut into 6 µm slices. TUNEL-staining was performed as 
described (see 3.4.1) and apoptotic liver cells per field of view (1.96 mm2) were counted 
with tissue samples from 4 animals of each treatment group (see 3.2.3 and 3.4.1 for 
details). * p ≤ 0.05 vs. controls. 
 
 
 
4.1.2.2 Effect of ANP on transaminase activity, LDH activity, and bile flow 
 
ANP preconditioning did not affect the plasma levels of liver transaminases alanine transaminase (ALT), 
aspartate transaminase (AST), or lactate dehydrogenase (LDH) as parameters for necrotic liver damage. 
Enzyme activities were measured in the serum of rats after 2 h of liver reperfusion (figure 18 A-C). In 
accordance, morphological analysis of necrotic liver cells by HE-staining did not reveal a difference 
between the ANP and the control group at both, 24 h ischemia as well as 2 h reperfusion. Furthermore, 
no significant effect on bile flow was observed during reperfusion (figure 18 D). 
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figure 18: ANP preconditioning does not influence serum transaminases and bile flow. Animals received an 
intravenous infusion of NaCl (Co) or ANP (5 µg/kg b.w.) for 20 min before the donor liver was 
explanted and kept under ischemic conditions (UW solution, 4 °C) for 24 h. A-C: after implantation 
of the organ into the recipient and reperfusion for 2 h, plasma samples (400 µl) were obtained. 
Activities of ALT, AST and LDH were measured as described in “Materials and Methods” and 
specified as units per liter serum with 7 animals in each group. D: bile was collected and quantified 
volumetrically (see 3.2.3 for details) with 7 animals in each group. 
 
 
 
4.1.2.3 PKA is not involved in the anti-apoptotic effect  
 
Since it has been shown that ANP mediates anti-apoptotic effects in the isolated perfused liver via 
phosphorylation of Bad by protein kinase A (PKA) (Kulhanek-Heinze,S. et al., 2004b), we investigated a 
possible participation of this pathway in vivo. Interestingly, however, ANP pretreatment of animals in vivo 
did not influence the activity of protein kinase A (PKA), as shown in figure 19. 
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figure 19: PKA is not involved in ANP-mediated hepatic effects. Animals received an intravenous infusion of 
NaCl (Co) or ANP (5 µg/kg b.w.) for 20 min. Livers were excised and homogenized as described in 
chapter 3.2.3 and 3.2.5). PKA activity was determined in liver homogenates by in vitro 
phosphorylation. Results are expressed as % of PKA activity in NaCl-treated livers (n=4). 
 
 
Also, in contrast to isolated perfused rat livers, ANP treatment in vivo did not alter Bad phosphorylation at 
the PKA specific phosphorylation site Ser 112 (see figure 20).  
 
 
 
 
 
 
figure 20: Phosphorylation of Bad at Ser 112 is not influenced by ANP pretreatment. After 
intravenous infusion of animals with NaCl (Co) or ANP (5 µg/kg b.w.) for 20 min, livers 
were excised and homogenized. Homogenates were immunoprecipitated using anti-Bad 
antibody (see 3.2.3 and 3.5). Levels of phospho-Bad (Ser 112) (p-Bad) were detected by 
Western Blot.  
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4.1.2.4 Involvement of the PI3-kinase pathway 
 
Since PKA-mediated Bad phosphorylation at Ser 112 could be excluded as the signaling pathway of anti-
apoptotic actions of ANP in vivo, we aimed to investigate the PI3-kinase pathway. PI3-kinase has been 
shown to mediate cytoprotective effects by pharmacological preconditioning (Müller,C. et al., 2003). 
As shown in figure 21, application of the PI3-kinase inhibitor Wortmannin (WM; 16 µg/kg b.w.) prior to 
ANP infusion completely blocked the inhibition of caspase-3-like activity by ANP seen in ischemic liver 
tissue. Thus, the PI3-kinase pathway is crucially involved in the anti-apoptotic effect of ANP 
preconditioning. 
 
 
 
 
 
 
 
 
 
 
 
figure 21: PI3-kinase mediates anti-apoptotic effects of ANP in vivo. Animals received an intravenous infusion 
of NaCl (Co), ANP (5 µg/kg b.w.), WM (16 µg/kg b.w.), or a combination of both (WM/ANP) for 20 
min. Livers were excised and snap-frozen. After 24 h ischemia livers were homogenized and 
caspase-3-like activity was determined as described in “Materials and Methods”. Data are 
expressed as percent of caspase-3-like activity in untreated livers (Co, 100%) with 4 animals in 
each group. ** p ≤ 0.01 vs. controls.  
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4.1.2.5 ANP preconditioning causes phosphorylation and translocation of Akt 
 
As the protein kinase Akt is an important downstream target of PI3-K we next investigated a possible 
effect of ANP on phosphorylation of Akt. 
Infusion of donor animals with ANP (5 µg/kg b.w.) for 20 min resulted in a marked increase of 
phosphorylated Akt (p-Akt) in the liver. This increase was abrogated in the presence of WM (figure 22). 
Akt activation by ANP seems to be a transient effect since it could not be observed after ischemia (24 h) 
or reperfusion (2 h) (data not shown). 
 
 
 
 
figure 22: ANP pretreatment increases Akt phosphorylation at Ser 473. After intravenous infusion of 
NaCl (Co), ANP (5 µg/kg b.w.), WM (16 µg/kg b.w.), or a combination of both (WM/ANP) 
for 20 min livers were excised and snap-frozen. Phospho-Akt (Ser 473) (p-Akt) was 
examined by Western Blot (see 3.2.3 and 3.5). 
 
 
Total levels of Akt were analyzed by Western Blot to confirm the uniformity of protein contents in the liver 
homogenates (figure 23). 
 
 
 
 
 
figure 23: Total protein levels of Akt after ANP preconditioning are unchanged in ischemic livers. 
Animals received an intravenous infusion of NaCl (Co) or ANP (5 µg/kg b.w.) for 20 min. 
Livers were excised and snap-frozen. Total amounts of Akt were examined by Western 
Blot (see 3.2.3 and 3.5). 
 
 
Analysis of p-Akt in liver tissue by confocal microscopy confirmed that ANP pretreatment led to a marked 
increase of p-Akt as already shown by Western Blot (see figure 22). Moreover, this analysis revealed a 
strong localization of p-Akt at the plasma membrane of hepatocytes (figure 24 A, B). Co-treatment of 
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animals with WM abrogated the increase as well as the plasma membrane localization of p-Akt induced 
by ANP (figure 24 C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
figure 24: Increase in Akt phosphorylation and changes in distribution of phospho Akt in liver tissue 
after ANP pretreatment. Animals were infused with NaCl (Co, A), ANP (5 µg/kg b.w.; B), or 
a combination of ANP and WM (16 µg/kg b.w.) (WM/ANP, C) for 20 min. Images were 
obtained as described in chapter 3.2.3 and 3.4.3 and examined by confocal microscopy 
(63-fold amplification). Blue: nuclei, red:  F-actin, cytoskeleton; green: p-Akt. 
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4.1.2.6 ANP-mediated phosphorylation of Bad 
 
To further examine the anti-apoptotic signaling by ANP in the liver induced in vivo, the Bad protein, an 
important downstream target of p-Akt, was investigated. The results indicate that Bad is phosphorylated 
at Ser 136 via p-Akt (figure 25). This phosphorylation is induced by ANP and completely independent of 
PKA-activation, since Ser 112 is the PKA specific phosphorylation site. 
 
 
 
 
 
 
 
figure 25: Phosphorylation of Bad at Akt-phosphorylation site Ser 136 is enhanced in ANP-pretreated 
livers after ischemia. After intravenous infusion of NaCl (Co), ANP (5 µg/kg b.w.), or ANP 
and WM (WM/ANP) for 20 min livers were excised and snap-frozen. Homogenized livers 
were immunoprecipitated using anti-Bad antibody. Examination of levels of phosphorylated 
Bad (Ser 136) (p-Bad) was done by Western Blot (for details see 3.2.3 and 3.5). 
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4.2 EFFECTS OF ANP DURING LPS-INDUCED SEPTIC SHOCK 
 
 
 
4.2.1 Effect of ANP pretreatment on survival after septic shock 
 
In order to investigate the effects of ANP on the survival of animals suffering from LPS-induced sepsis, 
we first determined the lethal LPS-dose for the present experimental setting. Administration of 1 mg 
LPS/kg b.w. caused worsening of the animals’ state of health (slight diarrhea, increase in body 
temperature, food refusal), which persisted during the entire experiment (food refusal until about 40 h 
after LPS injection) but did not affect survival (see figure 26). ANP treatment without LPS had also no 
effect on survival (see figure 26 and figure 27). Septic animals which were pretreated with ANP initially 
showed deterioration of their state of health but completely recovered from symptoms of LPS-induced 
sepsis. 
 
 
 
 
 
 
 
 
figure 26: Sublethal dose of LPS does not affect survival of animals. Animals were injected i.v. with ANP (5 
µg/kg b.w.; ANP- and ANP/LPS-group) or NaCl (Co and LSP-group), followed by an i.p. injection of 
NaCl (Co and ANP-group) or LPS (1 mg/kg b.w.; LPS- and ANP/LPS-group) after 20 min. The 
animals’ state of health was observed continuously for 72 h. For details see 3.3.3.1. 
 
 
Administration of LPS in a dose of 2.5 mg/kg b.w. caused an immediate worsening of the animals’ state of 
health already 1 h after i.p. injection of LPS. Mice had clotted eyelids, developed severe diarrhea and 
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fever, refused food and water, and became apathetic. These symptoms were observed in LPS- as well as 
in ANP/LPS-treated animals. All animals without ANP preconditioning died within 24.5 h due to severe 
symptoms of sepsis (figure 27). Interestingly, 80% of mice which had been pretreated with ANP 
recovered from septic shock (figure 27). After 24 h diarrhea attenuated and animals were more agile. 
They started drinking 27 h after LPS injection. Eyelid clotting diminished after 36 h and after 48 h mice 
still seemed to be debilitated but no longer refused food. Furthermore, blood heat declined and at the end 
of the survival experiment (72 h), ANP-pretreated mice showed an almost normal state of health without 
any fever or diarrhea. 
 
 
 
 
 
 
 
 
 
figure 27: Pretreatment with ANP reduces mortality after LPS-induced sepsis. Mice were injected i.v. with 
NaCl (Co and LPS-group) or ANP (5 µg/kg b.w., ANP- and ANP/LPS-group). After 20 min animals 
received an i.p. injection of NaCl (Co and ANP-group) or LPS (2.5. mg/kg b.w.; LPS- and ANP/LPS-
group). The animals’ state of health was observed continuously for 72 h. For details see 3.3.2.2 and 
3.3.3.1. 
 
 
 
4.2.2 Effects of ANP preconditioning on blood TNF-α levels after LPS- 
induced septic shock 
 
In order to investigate whether survival after ANP preconditioning is associated with changes in TNF-α 
levels in blood as an important parameter during sepsis, we determined the TNF-α concentrations in 
serum 90 min after LPS injection. At this time point TNF-α levels in the blood of LPS-treated animals 
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peaked and were detected by ELISA.  
As shown in figure 28, pretreatment with ANP caused a marked decrease in TNF-α serum levels. 
Sublethal (1 mg/kg b.w.) as well as lethal (2.5 mg/kg b.w.) doses of LPS caused this effect. 
 
 
 
 
 
 
 
 
 
 
 
figure 28: Preconditioning with ANP reduces TNF-α levels in blood samples 90 min after LPS-induced sepsis. 
Mice received an i.v. injection of NaCl or ANP (5 µg/kg b.w.) at the onset of the experiment. After 20 
min, LPS in a sublethal (1 mg/kg b.w.) or lethal (2.5 mg/kg b.w.) dose, or NaCl (ANP-group) was 
administered i.p.. 90 min later, 50 µl of tail-blood were used for determination of TNF-α 
concentration by ELISA (for details see 3.3). * p ≤ 0.05 vs. LPS-group, *** p ≤ 0.001 vs. LPS-group 
of the respective concentration. 
 
 
4.2.3 Effects of ANP on signaling during LPS-induced sepsis in the 
kidney 
 
4.2.3.1 ANP-mediated changes in NF-κB binding activity  
 
In our experiment, interestingly, examination of the kidneys after lethal anesthesia revealed obvious 
differences between LPS- and ANP-treated groups. While kidneys of LPS-injected mice were smaller 
than kidneys from control and their surface was wizened, the appearance of kidneys from ANP-treated 
animals resembled control organs with regular size and a smooth surface. Therefore, possible 
4 Results 
 
 
74
ANP/LPS ANPLPSNaCl
ANP/LPS ANPLPSNaCl
A
B
mechanisms responsible for the ANP-mediated effects on TNF-α level (4.2.25.2.2) and survival of 
animals (4.2.15.2.1) where further investigated in the kidney. 
NF-κB is one of the most important mediators of the LPS signaling pathway. Thus, modifications in 
binding activity of NF-κB as a possible reason for changes in serum TNFα-levels were investigated. 
As illustrated in figure 29, LPS treatment caused a significant increase in NF-κB binding activity in the 
kidney. This effect is characteristic for LPS-induced sepsis. The basal NF-κB binding activity in tissue of 
NaCl-treated animals was very low and ANP injection alone had no effect on this parameter. 
Preconditioning with ANP, however, provoked a significant decrease of NF-κB binding activity during 
endotoxemia as soon as 15 min after LPS injection (figure 29 A), further decreasing after 30 min (figure 
29 B). 
 
 
 
 
 
 
 
 
 
 
 
 
figure 29: ANP pretreatment reduces NF-κB binding activity in the kidney after LPS-induced sepsis. 
Animals received an i.v. injection of NaCl (Co) or ANP (5 µg/kg b.w.) 20 min prior to i.p. 
injection of LPS (1 mg/kg b.w.). Co: NaCl-treated; ANP: ANP i.v., after 20 min NaCl i.p.; 
LPS: NaCl i.v., after 20 min LPS i.p.; ANP/LPS: ANP i.v., 20 min later LPS i.p.. 15 min (A) 
or 30 min (B) after LPS injection kidneys were excised, snap-frozen, homogenized, and 
investigated by EMSA (for details see 3.3 and 3.6). 
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4.2.3.2 Effect of ANP on distribution of the NF-κB subunit p65 after LPS-induced sepsis 
 
To confirm the data of NF-κB binding activity detected by EMSA, we focused on the distribution of the NF-
κB subunit p65. NF-κB-translocation was investigated by staining of the p65 subunit in snap-frozen slices 
of kidney tissue and images were obtained by confocal microscopy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
figure 30: ANP prevents translocation of the NF-κB subunit p65 into the nucleus. Animals received 
an i.v. injection of NaCl or ANP (5 µg/kg b.w.) 20 min before i.p. injection of NaCl or LPS (1 
mg/kg b.w.). Four treatment groups were investigated: Controls (NaCl) received NaCl 
injections only; ANP: ANP i.v. and NaCl i.p. 20 min later; LPS: NaCl i.v. and LPS i.p. 20 
min later; ANP/LPS: ANP i.v., LPS i.p. after 20 min. 30 min after LPS-injection (t = 30 min) 
kidneys were excised, snap-frozen, and slices were stained. Blue: nuclei, red: p65. Images 
were obtained as described in chapter 3.3.3.2 and 3.4.3. 
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As illustrated by confocal microscopy, p65 translocated into the nuclei of kidney cells after LPS treatment 
(figure 30). Pretreatment with ANP prevented this translocation shown by marginal location of p65 in the 
cytosol. 
 
4.2.3.3 Protein level of total IκBα and phosphorylation of IκBα 
 
We were now interested in the mechanisms responsible for ANP-mediated inhibition of NF-κB. 
In NaCl-treated animals (Co) basal levels of total IκBα and phosphorylated IκBα could be detected (figure 
31). ANP treatment had no effect on the amount of total IκBα or the phosphorylation of IκBα. Increased 
phosphorylation of IκBα was detectable 15 min after injection of LPS (figure 31 A). This effect became 
even more obvious in kidneys excised 30 min after LPS injection (figure 31 B). Simultaneously, we 
observed decreased levels of total IκBα in kidneys of LPS-treated animals, pointing to an increased 
degradation of the NF-κB inhibitor. In contrast, ANP preconditioning caused only a slight decrease in 
phosphorylation of IκBα. This resulted in minor degradation of IκBα and thus a higher content of total IκBα 
in the samples (figure 31). 
 
 
 
 
 
 
 
 
 
 
 
figure 31: After LPS-induced sepsis ANP pretreatment causes decreased phosphorylation of IκBα and 
increased content of total IκBα compared to samples of the LPS-group. 20 min after i.v. injection of 
NaCl or ANP (5 µg/kg b.w.) animals were injected i.p. with NaCl or LPS. Co: NaCl treatment only; 
ANP: ANP i.v., 20 min later injection of NaCl; LPS: NaCl i.v. before LPS i.p. after 20 min; ANP/LPS: 
ANP i.v., 20 min later LPS i.p.. 15 min (A), and 30 min after LPS injection respectively (B), kidneys 
were excised, snap-frozen and analyzed by Western Blot (3.3.3.2 and 3.5.) 
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5.1 EFFECTS OF ANP DURING ISCHEMIA AND REPERFUSION IN 
THE LIVER 
 
5.1.1 Ex vivo pretreatment with ANP causes p38 MAPK-dependent 
changes in hepatocytes cytoskeleton 
 
In previous studies we demonstrated that ANP and IR influence the cytoskeleton in liver tissue (diploma 
thesis). Although hepatic content of total actin is affected neither by IR alone nor by pretreatment of livers 
with ANP, we observed increased levels of filamentous actin (F-actin) in ANP-pretreated livers. This 
augmentation of F-actin content was observed in fractions containing plasma membranes of whole livers, 
but the involved cells were not identified. Since F-actin is know to play a crucial role in stabilization of the 
cytoskeleton and consequently in preservation of an intact cell morphology (Banan,A. et al., 2000), these 
ANP-mediated changes were suspected to be an essential part of the peptide’s cytoprotective action 
during IR (Gerbes,A.L. et al., 1998b). 
Our data also showed that ANP preconditioning ex vivo provokes changes in protein levels and in 
localization of the small heat shock protein Hsp27. While ischemic livers showed a shift of Hsp27 from the 
cytosolic to the cytoskeletal fraction, ANP pretreatment completely abrogated this translocation of the 
heat shock protein. These findings correlated with a translocation of Hsp27 to the cytoskeleton which was 
observed after ischemia and reoxygenation in a myoblast cell line (Sakamoto,K. et al., 1998), in the 
isolated rat heart (Sakamoto,K. et al., 2000a), and in vivo in the rabbit heart (Sakamoto,K. et al., 2000d, 
Sanada,S. et al., 2001c). Moreover, Huot et al. showed that Hsp27 has protective properties in CCL39 
cells with respect to cytoskeletal damage which can be caused by oxidative stress (Huot,J. et al., 1996). 
Subsequently, the results of the diploma thesis led to the question about possible signaling pathways 
participating in alteration of actin polymerization, translocation of Hsp27, and the potential of 
activation/phosphorylation of the heat shock protein. In addition, it had to be analyzed which cell type in 
the liver shows cytoskeletal changes mediated by ANP and whether there are any functional 
consequences during IR. 
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5.1.1.1 Role of p38 MAPK in ANP-mediated cytoskeletal changes in the liver after ischemia 
 
 
ANP has previously been shown to lead to a marked activation of the mitogen-activated protein kinase 
(MAPK) p38 (Kiemer,A.K. et al., 2002h). However, to date there are no data about functional 
consequences of this activation in the liver. Interestingly, this protein kinase has been shown to cause 
cytoskeletal changes in various in vitro systems, for example in cultured Chinese hamster CCL39 cells, 
HeLa cells, Chinese hamster fibroblasts, and pancreatic acini (Guay,J. et al., 1997, Landry,J. et al., 
1995f, Schafer,C. et al., 1998). Nevertheless, similar pathways in the liver are as yet unknown. We were 
therefore interested whether p38 MAPK is involved in the cytoskeletal changes we found in ANP-treated 
livers after ischemia. 
In order to test this hypothesis, we applied the p38 MAPK inhibitor SB203580 at a concentration of only 2 
µM to assure its specificity (McGovern,S.L. et al., 2003). Importantly, the inhibitor completely abolished 
the ANP-induced effect of increased F-actin content in pretreated livers. Thus, we show for the first time 
that ANP-mediatedp38 MAPK activation (Kiemer,A.K. et al., 2002g) leads to hepatic cytoskeletal changes 
by an increase of the hepatic F-actin content in rat livers. 
 
 
5.1.1.2 Phosphorylation status of Hsp27 
 
In previous studies we showed that ex vivo preconditioning with ANP causes changes in protein levels 
and localization of the small heat shock protein Hsp27 (diploma thesis). It is known that these changes, 
as well as the function of Hsp27, largely depend on the phosphorylation status of the heat shock protein 
(Benndorf,R. et al., 1994a, Lutsch,G. et al., 1997). Thus, in subsequent investigations we focussed on 
this parameter. 
In fact, our results clearly point to an influence of ANP on the phosphorylation status of Hsp27 after the 20 
min preconditioning period as well as after 24 h ischemia. The correlation between ANP preconditioning 
and phosphorylation of Hsp27 resembles data presented by Sanada et al., showing increased Hsp27 
phosphorylation after ischemic preconditioning in the heart in vivo (Sanada,S. et al., 2001b). 
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In addition, our data show that ischemic conditions cause phosphorylation of Hsp27 in isolated perfused 
rat livers. This is in line with the results of Huot et al. demonstrating an increased content of 
phosphorylated Hsp27 in Chinese hamster CCL39 cells and human umbilical vein endothelial cells 
(HUVECS) respectively, after exposure to cellular stressors like TNF-α or H2O2 (Huot,J. et al., 1995, 
Huot,J. et al., 1997). 
Little is known about the downstream targets of hepatic p38 MAPK activation by ANP. However this 
protein kinase has been demonstrated to play an important role in the liver for example in regulation of 
translational processes upon cellular stress, influencing production of TNF-α and IL-1 after burn-induced 
liver injury, and in vivo p38 has been demonstrated to activate the transcription factor AP-1 and 
MAPKAPK2 after heat shock (Chen,X.L. et al., 2005, Maroni,P. et al., 2000, Wang,X. et al., 1998). 
Previous experiments have shown that phosphorylation of Hsp27 is exhibited by the p38 MAPK / 
MAPKAPK2 pathway in other systems (Freshney,N.W. et al., 1994a, Landry,J. et al., 1995g, 
Murashov,A.K. et al., 2001a, Nakano,A. et al., 2000b, Sanada,S. et al., 2001a). For this reason, we 
investigated the importance of p38 MAPK in the phosphorylation of Hsp27 in ANP-pretreated livers after 
ischemia. 
Livers were perfused with SB203580 in combination with ANP. In fact, an inhibition of p38 MAPK 
decreased the phosphorylation status of Hsp27 to basal levels. Thus, our results clearly prove the 
dependency of Hsp27 phosphorylation on previous activation of p38 MAPK in the liver. 
 
 
5.1.1.3 Functional consequences of changes in hepatocytes cytoskeleton 
 
The results of the final year project (diploma thesis) pointed out ANP-mediated changes in cytoskeletal 
structures of preconditioned liver cells during IR. In the present work, we clearly demonstrate that ANP 
pretreatment causes an increase in F-actin content, which occurs particularly at the plasma membranes 
of hepatocytes after ischemia. 
In hepatocytes, a decrease in hepatic F-actin content determines inhibition of store-operated calcium-
channels (SOCs), disruption of the organization of the endoplasmic reticulum, and functional disturbances 
of tight junctions (Marceau,N. et al., 2001, Song,J.Y. et al., 1996b, Wang,Y.J. et al., 2002b). In addition, 
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increased hepatic F-actin levels are thought to stabilize the cytoskeleton and to improve contractility 
which results in improved bile flow after ischemia (Rungger-Brandle,E. et al., 1983). 
Recently, Gomes et al. proved that ischemic preconditioning (IPC) preserves rat kidneys from IRI. The 
improved function and morphology of kidney tissue was accompanied by an upregulation of genes 
encoding for cytoskeletal proteins. The demonstrated increase in mRNA levels of these proteins, which 
have an F-actin-stabilizing function and are therefore crucial for the maintenance of cellular structures, is 
suggested to improve tolerance of preconditioned tissue to ischemia (Gomes,M.D. et al., 2003). The 
augmented transcription of cytoskeletal proteins is already observed after 30 min of preconditioning. Our 
findings of an increased F-actin content in ANP-preconditioned livers are therefore suggested to be a 
consequence of enhanced synthesis of this cytoskeletal protein. Thus, the influence of protective 
preconditioning (IPC or ANP pretreatment) on F-actin content of the affected tissue is confirmed. ANP 
preconditioning as well as IPC defends the liver from IRI (for review see (Carini,R. et al., 2003c)). 
Furthermore, F-actin plays a crucial role in regulation of cell morphology, intracellular transport 
processes, exo- and endocytosis, and canalicular motility responsible for bile flow (Denk,H. et al., 1986, 
Fisher,M.M. et al., 1979, Marceau,N. et al., 2001). In addition cytoskeletal structures are important to 
ensure stability and mobility of liver cells (Arias I.M., 2001a). 
We therefore hypothesized that an augmentation of hepatic F-actin after ischemia might be a feature of 
the cytoprotective activities of ANP. Surprisingly, we found no improvement of bile flow although F-actin 
content increases in the pretreated organs. In consequence, in the isolated perfused liver the ANP-
mediated effect on the cytoskeletal structure of hepatocytes might just not be strong enough to facilitate a 
correlation between ANP pretreatment and protection of the liver against IRI with respect to functional 
parameters. Thus, further targets of ANP-induced signaling which might be responsible for cytoprotective 
effects of the peptide have to be investigated in the future. 
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5.1.2 ANP treatment in vivo has anti-apoptotic effects mediated via the 
PI3-kinase pathway                                                                      
 
 
5.1.2.1 ANP reduces apoptotic cell death in liver tissue 
 
The type of cell death occurring during hepatic IR as well as the importance of apoptosis versus necrosis 
remains a controversial issue. In this context, Gu et al. and Rosser et al. proposed that necrotic cell death 
is the main cause of tissue damage during IR (Gu,X.P. et al., 2004, Rosser,B.G. et al., 1995b). Gujral et 
al. share this opinion in a paper in which they assess this type of cell death in liver tissue during IR 
according to morphological criteria, TUNEL staining of tissue, and caspase-activity in liver samples as the 
only relevant (Gujral,J.S. et al., 2001a). On the other hand, there are numerous studies demonstrating 
that liver cells die of apoptotic cell death. It has been shown that 50-70% of endothelial cells and 40-60% 
of hepatocytes undergo apoptosis during reperfusion (Gao,W. et al., 1998b, Kohli,V. et al., 1999a). 
Furthermore, it has previously been demonstrated that in vivo application of caspase inhibitors leads to a 
complete abrogation of cell death in hepatocytes and protects against IRI, thus referring to apoptosis as 
the major type of cell death during IR (Cursio,R. et al., 1999b). Application of a specific inhibitor of 
caspase 3 and 7 even causes improved survival after IR in rat liver transplantation supporting a critical 
role of apoptotic cell death for loss of function of this organ (Mueller,T.H. et al., 2004b). Since Gerwig et 
al. proved that ANP pretreatment prevents apoptosis in the model of the isolated perfused liver with major 
effects after 24 h cold ischemia (Gerwig,T. et al., 2003b), we were now interested whether 
preconditioning in vivo protects the liver from IRI and which signaling pathways are involved in the effect 
of the peptide hormone with regard to apoptotic cell death during IR. 
Our results clearly demonstrate that ANP-treated livers display a marked decrease of caspase-3-like 
activity by around 30% compared to control. Additionally, the number of TUNEL-positive cells in ANP-
preconditioned livers is significantly lower than in controls. This reduction of apoptotic cell death is an 
important parameter for cytoprotective effects in vivo following IR, as demonstrated in numerous studies. 
Vilatoba et al. for example presented a correlation of decreased apoptotic cell death and improvement of 
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liver regeneration and survival after warm ischemia in 17-betaestradiol-treated mice (Vilatoba,M. et al., 
2005). Ischemic preconditioning, which has been proven to reduce IRI in many cases, also leads to an 
inhibition of apoptosis of liver cells demonstrating the importance of this type of cell death during IR 
(Glanemann,M. et al., 2004). Moreover, Contreras et al. showed that the application of caspase-3 small 
interference RNA, which specifically suppresses the expression of the gene encoding for caspase-3, 
protects from IRI by improving functional parameters and morphology of liver tissue in vivo 
(Contreras,J.L. et al., 2004b). As our results revealed that ANP in vivo causes a decline in apoptotic cell 
death in liver tissue after ischemia, these data point to a beneficial effect of the peptide in liver 
transplantation. 
 
 
5.1.2.2 Anti-apoptotic effects of ANP preconditioning in vivo are not mediated via PKA 
 
Based on recent findings of Kulhanek et al. indicating activation of PKA as a key event in prevention of 
hepatic IRI after cold ischemia ex vivo (Kulhanek-Heinze,S. et al., 2004a), we investigated the role of 
PKA activity in our in vivo model of liver IR. In contrast to Kulhanek et al., who showed an inhibition of 
anti-apoptotic effects of ANP via inhibition of PKA, we could clearly demonstrate that this kinase is not 
involved in ANP-mediated anti-apoptotic effects in vivo: there was neither a detectable change in PKA 
activity nor in the phosphorylation status of the downstream target Bad at its PKA-specific 
phosphorylation site Ser 112 (Harada,H. et al., 1999). Since Kulhanek et al. performed their experiments 
ex vivo in the model of isolated perfused rat liver the controversial observations are explainable by the 
different experimental settings used. Therefore, we concentrated on other signaling pathways possibly 
involved in the anti-apoptotic effects of ANP. 
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5.1.2.3 ANP-mediated in vivo effects involve the PI3-kinase pathway: Phosphorylation and 
translocation of Akt 
 
Cullen et al. recently demonstrated anti-apoptotic effects in hepatocytes to be mediated via PI3-kinase 
activation and completely independent of PKA (Cullen,K.A. et al., 2004). Due to the importance of this 
kinase as a mediator of cellular survival (Datta,S.R. et al., 1999b, Osaki,M. et al., 2004b), we 
subsequently focused on the PI3-kinase pathway. 
By using the PI3-kinase inhibitor Wortmannin (WM) which completely abrogated inhibition of caspase-3-
like activity after ANP pretreatment, we demonstrated that anti-apoptotic effects of ANP depend on a 
preceding activation of PI3-kinase. This observation is in line with results obtained by Tong et al. and 
Mocanu et al. showing that in the heart repression of the PI3-kinase pathway by administration of WM 
abrogated protective effects of ischemic preconditioning (IP) (Mocanu,M.M. et al., 2002, Tong,H. et al., 
2000). Also in preconditioned hepatocytes PI3-kinase inhibition abolishes the tolerance to hypoxic 
damage, therefore confirming the assumption that protective effects of IP are mediated via the PI3-kinase 
pathway (Carini,R. et al., 2004). 
To elucidate ANP-mediated signaling mechanisms involving the PI3-kinase pathway we next focussed on 
an important downstream target of the PI3-kinase: the survival kinase Akt. This kinase plays a pivotal role 
in anti-apoptotic signaling (Armstrong,S.C., 2004, Downward,J., 2004a). As previously demonstrated, Akt 
is rapidly activated after partial hepatectomy and is important for survival of hepatocytes, regeneration of 
the liver, and also protection of the heart against IRI (Hausenloy,D.J. et al., 2005a, Hong,F. et al., 2000). 
It is known that activity of Akt is regulated via binding of phosphatidylinositol 3,4,5 triphosphate (PIP3) and 
PI(3,4)P2 located at the plasma membrane of the affected cells. This causes the translocation of Akt from 
the cytosol to the plasma membrane followed by its phosphorylation (Datta,S.R. et al., 1999a). Regarding 
these facts we investigated whether ANP pretreatment influences the distribution and phosphorylation 
status of Akt in hepatic cells. 
Our findings which showed a significant augmentation of phospho-Akt levels in ANP-pretreated livers 
support results of Kook et al. (Kook,H. et al., 2003) who found an increased phosphorylation of Akt in 
endothelial cells after ANP preconditioning. According to recent findings, an activation of Akt in the liver 
during warm IR in vivo is also protective (Harada,N. et al., 2004c). This strengthens our hypothesis that 
ANP exerts protective, anti-apoptotic effects via an activation of Akt. 
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With respect to the localization of Akt we observed a translocation of the kinase from the cytosol to the 
plasma membrane in hepatocytes of ANP-pretreated livers. This translocation has been suggested to be 
a consequence of binding of the PIP2 and PIP3 to Akt and is essential for activation of Akt (Datta,S.R. et 
al., 1999g). This has also been demonstrated by studies investigating the protective effects of Akt in vitro 
in cardiomyocytes as well as in vivo in heart and liver using an adenoviral construct encoding for a 
constitutively-active, membrane-targeted form of Akt (Harada,N. et al., 2004b, Hausenloy,D.J. et al., 
2005b, Matsui,T. et al., 1999, Miao,W. et al., 2000). 
Based on our findings demonstrating ANP-mediated anti-apoptotic effects on ischemic liver cells in vivo 
via Akt, we subsequently focused on possible downstream targets of the survival kinase involved in the 
anti-apoptotic signaling. 
 
 
5.1.2.4 Bad is phosphorylated by Akt after ANP pretreatment in vivo 
 
In its unphosphorylated form, the apoptosis-regulating factor Bad acts as an inhibitor of anti-apoptotic 
proteins like Bcl-2 or Bcl-XL and thus promotes apoptotic processes (Chao,D.T. et al., 1998, Wang,H.G. 
et al., 1999). After phosphorylation at Serine (Ser) 112 by PKA or at Ser 136 by Akt, Bad detaches from 
Bcl-2 or Bcl-XL thereby facilitating anti-apoptotic effects (Datta,S.R. et al., 1999i). Phosphorylation of Bad 
via Akt at Ser 136 is one essential event responsible for the anti-apoptotic effects of the survival kinase 
(Datta,S.R. et al., 1999h). Thus, inhibition of PI3-kinase and subsequently decreased phosphorylation of 
its downstream target Akt reverses the protective effects of Akt-activation. In this context, Harada et al. 
showed in a different model of IR in vivo that Bad phosphorylation plays a crucial role in protection of liver 
cells against apoptotic cell death (Harada,N. et al., 2004a). Our data demonstrate that application of WM, 
thus inhibiting the PI-3kinase pathway, not only prohibits phosphorylation and subsequently activation of 
Akt but also prevents Bad phosphorylation. With regard to the phosphorylation site of Bad being 
responsible for the anti-apoptotic effects of Akt we demonstrated that Ser 136 is phosphorylated while 
phosphorylation at Ser 112 is completely unaffected after ANP preconditioning. It has been shown that 
mutation of Ser 136 to alanine causes abrogation of survival-promoting properties of Akt. On the other 
hand, mutation of Bad at Ser 112 has no influence on Akt-mediated anti-apoptotic signaling (Datta,S.R. et 
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al., 1999j). 
Based on this knowledge we clearly demonstrated that ANP mediates its anti-apoptotic effects in the liver 
after IR in vivo via the PI3-kinase / Akt pathway and subsequent phosphorylation of Bad at Ser 136. 
 
 
5.1.2.5 No effect on transaminase activity and bile flow after ANP pretreatment in vivo 
 
Due to our findings that ANP pretreatment in vivo reduces apoptosis in liver tissue after IR we finally 
aimed to elucidate functional consequences of this effect in the liver. The data of Gerwig et al. (Gerwig,T. 
et al., 2003a) clearly demonstrate a decrease in necrotic cell death in combination with anti-apoptotic 
effects in ANP-preconditioned livers. In contrast, we were not able to show anti-necrotic effects of the 
peptide in vivo. Interestingly, Cursio et al. found out that an application of caspase-inhibitors blocks 
apoptosis in liver tissue thereby assuring survival of 95 % of the animals after lethal warm liver ischemia, 
and assigning the major role in cell death during IR to apoptosis (Cursio,R. et al., 1999a). However, they 
furthermore showed that despite a complete inhibition of caspases, the activity of transaminases, though 
drastically reduced, remains relatively high. Apoptotic cell death is therefore assumed to be accompanied 
by necrosis of liver cells during IR. Regarding the nonexisting improvement of bile flow after 
transplantation, the results of Mueller et al. are interesting to discuss (Mueller,T.H. et al., 2004a). They 
demonstrated improved survival of rats after liver transplantation provoked by application of a caspase-3-
inhibitor but could not observe any melioration regarding bile flow after transplantation. In our setting, 
ANP preconditioning in vivo only reduced caspase-3-like activity after ischemia to about 60%. This 
inhibitory effect might not be strong enough to have an influence on the amount of necrotic cells pointing 
to a possible explanation for the inability of ANP to influence transaminase activity. 
With regard to parameters of liver function, our results furthermore indicate that apoptotic cell death in 
liver cells is not the only parameter leading to tissue damage and dysfunction. Though caspase-3-like 
activity increases after ischemia in untreated cells and ANP preconditioning prevents this augmentation, 
the portion of liver cells dying from apoptosis may be too small to be solely responsible for tissue 
damage. Therefore, inhibition of apoptosis during IR does not necessarily cause general protection of the 
organ. This opinion is also represented by Gujral et al., reasoning that if apoptosis was the primary 
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mechanism of cell death leading to IRI, inhibition of apoptotic processes, like caspase activity, should 
rapidly ameliorate organ function (Gujral,J.S. et al., 2001d). 
Another explanation for the lack of beneficial effects by ANP on functional parameters might be the 
experimental setting itself. Although Cottart et al. investigated influence of the peptide in the liver in vivo 
and observed a decrease in AST (-30%) and LDH (-40%) plasma activity after 1 h reperfusion 
(Cottart,C.H. et al., 2003d), it has to be mentioned that a completely different experimental setting was 
used. Warm partial ischemia (37 °C) was performed for 45 min followed by liver perfusion for up to  
6 h. Furthermore, the ANP dose used was twice as high as in our experiments (10 µg/kg b.w.) and livers 
were not transplanted, but reperfused after ischemia. Thus, in our model of ANP preconditioning before 
cold ischemia in vivo, the protective impact of the peptide may just not be strong enough to lead to a 
significant beneficial outcome after liver transplantation. 
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5.2 EFFECTS OF ANP DURING LPS-INDUCED SEPTIC SHOCK 
 
 
5.2.1 ANP preconditioning maintains survival after LPS-induced septic 
shock 
 
In previous studies of our group ANP has been shown to possess anti-inflammatory and cytoprotective 
properties in vitro after stimulation of HUVECs with TNF-α (Kiemer,A.K. et al., 2002u, Kiemer,A.K. et al., 
2002q, Weber,N.C. et al., 2003a). Moreover, we demonstrated that ANP exhibits anti-inflammatory 
effects in bone marrow derived macrophages after stimulation with LPS (Kiemer,A.K. et al., 2000c, 
Kiemer,A.K. et al., 2002n). In LPS-mediated activation of KC the peptide increased phagocytosis activity 
of KC and reduced TNF-α secretion (Kiemer,A.K. et al., 2002c). Besides these in vitro observations, 
inhibition of the ANP receptor binding involved inflammation in vivo in rats with serotonin (5-HT2A) 
receptor- mediated acute hemodynamic changes (Tozawa,Y. et al., 2002a). In LPS-treated mice, 
preconditioning with ANP markedly reduced thromboxane B2 level in the blood, also pointing to anti-
inflammatory properties of ANP (Kiemer,A.K. et al., 2002o). 
The findings of Qu et al. point to a possible participation of ANP in regulation of plasma volume during 
endotoxemia (Qu,X.W. et al., 1998b). Additionally, increased plasma ANP levels have been observed in 
patients with septic shock (Lubbesmeyer,H.J. et al., 1988, Mitaka,C. et al., 1993), and Morgenthaler et al. 
even discuss Pro-ANP as a prognostic marker in sepsis (Morgenthaler,N.G. et al., 2005c). During 
endotoxic shock augmentation of ANP concentrations in the plasma persists until 24 h after LPS injection 
(Aiura,K. et al., 1995a). These findings allude to a role of ANP as a protective endogenous regulator of 
defensive mechanisms during inflammatory processes in vivo. To date, however, there are no data 
explaining the signaling mechanism responsible for ANP-mediated effects during endotoxemia. Therefore 
we were now interested whether ANP exhibits anti-inflammatory actions in vivo in a murine model of LPS-
induced endotoxemia thereby influencing survival of animals. 
Lethal LPS doses in murine models of endotoxemia highly vary and depend on origin, quality, and 
manufacturer of LPS samples used for experiments (Gorgen,I. et al., 1992c, Kuhnle,S. et al., 1999, 
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Tiegs,G. et al., 1994). On this account, we first determined the lethal LPS dose for our experimental 
setting of LPS-induced sepsis in mice. Using LPS from Salmonella abortus equi, we figured out that i.p. 
injection of 3 mg/kg b.w. LPS is lethal to mice, whereby 100 % of the animals die within 25 h. 
Interestingly, ANP pretreatment protects mice against LPS-induced sepsis in vivo and guarantees 80 % 
survival of the animals even 72 h after LPS administration. 
Based on these results we subsequently focused on the mechanism involved in ANP-mediated survival 
after LPS-induced sepsis. 
 
 
5.2.2 ANP causes reduction of serum TNF-α concentration after LPS-
induced sepsis 
 
TNF-α is one of the central pro-inflammatory cytokines and a prominent marker for inflammatory 
processes during sepsis (Gorgen,I. et al., 1992b, Guha,M. et al., 2002, Munoz,C. et al., 1991). 
The serum levels of this cytokine are markedly increased during the inflammatory response to LPS in a 
murine model of septic shock (Barsig,J. et al., 1995). As Gorgen et al. point out coherence between 
suppression of TNF-α production and survival of mice after LPS-induced septic shock (Gorgen,I. et al., 
1992a), we were interested in the effects of ANP on serum TNF-α levels during endotoxemia. 
Interestingly, ANP preconditioning reduces TNF-α concentration up to 50 % compared to LPS-treated 
animals. In vitro ANP has previously been demonstrated to possess anti-inflammatory activities. Prior 
studies showed that the production of TNF-α is inhibited by ANP pretreatment in murine macrophages 
stimulated with LPS, and Interferon-gamma respectively (Kiemer,A.K. et al., 2000d, Tsukagoshi,H. et al., 
2001c). Furthermore, ANP treatment abrogates LPS-induced increase of TNF-α in human blood and 
reduces TNF-α secretion and phagocytotic activity of rat Kupffer cells (KC) (Kiemer,A.K. et al., 2000e, 
Kiemer,A.K. et al., 2002d). 
However, the role of the TNF-α level in serum as a prognostic marker during sepsis for survival of 
patients and the clinical relevance of an anti-TNF-α therapy are discussed controversially. On the one 
hand, Atici et al. reported that in infants suffering from sepsis, TNF-α levels are significantly elevated, but 
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are not different in surviving and non-surviving neonates (Atici,A. et al., 1997). Thus, the authors conclude 
that there is no correlation between TNF-α serum concentration and the outcome of neonatal sepsis. On 
the other hand, Collighan et al. and Damas et al. showed that a decrease in serum TNF-α level is directly 
linked to survival of septic patients and is therefore suitable for an estimation of sepsis severity score 
(Collighan,N. et al., 2004, Damas,P. et al., 1989). With respect to efficacy of anti-TNF-α compounds 
during sepsis some studies revealed only small survival benefit as described by Reinhart et al. 
(Reinhart,K. et al., 2001). However, it has recently been demonstrated that Afelimomab, a monoclonal 
anti-TNF-α antibody fragment, reduces mortality and attenuates the severity of organ dysfunction in 
patients with severe sepsis (Panacek,E.A. et al., 2004). Moreover, Matsumoto et al. demonstrated in a 
murine model of gut-derived sepsis that treatment with an anti-TNF-α monoclonal antibody significantly 
increases survival of animals, whereas application of recombinant human TNF-α increases the mortality 
rate in comparison to saline-treated mice (Matsumoto,T. et al., 1997). In fact, the results of the present 
study suggest for our experimental setting an inverse correlation between the serum TNF-α levels and 
survival of animals. Pretreatment and thus inhibition of production of TNF-α might prevent increase in 
serum levels of this cytokine and could be a key event in facilitating survival in the present study. 
Therefore, signaling pathways leading to TNF-α release are an important target for ANP mediated 
protective effects in LPS-induced sepsis and were therefore further investigated. 
 
 
5.2.3 Intervention of ANP into LPS-signaling in the kidney 
 
ANP has been demonstrated to play a protective role during inflammatory processes and in the kidney 
regarding acute renal failure (Lieberthal,W. et al., 1990, Raine,A.E. et al., 1989). Due to leukocytes 
infiltration, inflammatory processes such as activation of NF-κB and subsequent increased expression of 
inflammatory genes in mesangial cells, renal tubular epithelial cells, and urothelial cells this organ is 
seriously affected during sepsis (Gjertsson,I. et al., 2001b, Guijarro,C. et al., 2001b). Furthermore, ANP 
levels have been demonstrated to be increased in kidneys of sheep suffering from endotoxemia, thereby 
influencing renal functions (Hinder,F. et al., 1996). 
Our experiments, interestingly, revealed that kidneys from LPS-treated animals were obviously damaged, 
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those from ANP-injected mice were hardly affected in their structural appearance pointing to ANP-
induced effects in this organ. 
Based on the observation of decreased serum TNF-α levels in ANP-treated septic animals and the 
knowledge that this cytokine is regulated via NF-κB (Barnes,P.J. et al., 1997), we next investigated the 
role of NF-κB in ANP-mediated effects during endotoxemia. NF-κB is an important component regulating 
the inflammatory and immune response by inducing the expression and release of cytokines and other 
pro-inflammatory mediators (Blackwell,T.S. et al., 1997b, Hayden,M.S. et al., 2004). Abraham et al. 
furthermore demonstrated that activation of NF-κB dependant pathways is crucial for the development of 
septic shock and thus, regulation of this parameter is an attractive therapeutic option (Abraham,E., 2003).  
Activation of NF-κB plays a crucial role in inflammatory processes causing severe damage of the kidneys 
as shown in models of systemic inflammation, nephritis, tubulointerstitial disorders, and proteinuria 
(Guijarro,C. et al., 2001c). Pocock et al. observed in kidneys of LPS-tolerant rats a significant 
downregulation of NF-κB activity (Pocock,J. et al., 2003). Although Gjertsson et al. show that 
administration of antisense oligonucleotides to the p65-subunit of NF-κB has no effect on the clinical 
outcome of septic arthritis or sepsis (Gjertsson,I. et al., 2001a), there are definitely more data indicating 
the inhibition of NF-κB activity as a promising target for anti-inflammatory therapies of renal diseases. 
Thus, Tamada et al. demonstrate that inhibition of NF-κB activation prevents renal fibrosis and interstitial 
inflammation in chronic tacrolimus (FK506) nephropathy (Tamada,S. et al., 2003). Additionally, prevention 
of NF-κB activation by an application of anti-inflammatory substances like partenolide and gliatoxin 
improves the outcome of experimental glomerulonephritis in rats (Lopez-Franco,O. et al., 2002a). The 
kidneys of either partenolide- or gliatoxin-treated animals showed an inhibition of NF-κB activity combined 
with protection against renal lesions, proteinuria and monocyte infiltration. Further in vivo studies also 
suggest the inhibition of NF-κB activity to be responsible for anti-inflammatory and thus renal protective 
effects of the glucocorticoid prednisolon making this transcription factor an important target for continuing 
investigation (Komiya,T. et al., 2004, Sakurai,H. et al., 1997). 
In vitro ANP has been shown to possess anti-inflammatory properties causing a reduction of NF-κB 
binding activity in LPS-stimulated, and Interferon-gamma-activated murine macrophages respectively 
(Kiemer,A.K. et al., 1998b, Tsukagoshi,H. et al., 2001a). In human cells (HUVECs) ANP-treatment 
prevented TNF-α-induced NF-κB activity (Kiemer,A.K. et al., 2002t). Moreover, it has been demonstrated 
that ANP prevented the increase of NF-κB activity occurring during reperfusion in ischemic rat livers and 
5 Discussion 
 
 
92
Irwin et al. previously demonstrated that treatment with ANP prevents hypoxia-induced activation of NF-
κB in bovine pulmonary endothelial cells (Irwin,D.C. et al., 2005a, Kiemer,A.K. et al., 2000j). Vellaichamy 
et al. additionally observed an activation of NF-κB in vivo due to absence of ANP-mediated anti-
inflammatory actions in hearts of mice lacking the gene encoding for the ANP receptor (NPR-A) 
(Vellaichamy,E. et al., 2005). 
In the present study investigation of NF-κB binding activity in kidneys of septic mice clearly reveals that 
the NF-κB binding activity increases in the kidney during endotoxaemia. Interestingly, pretreatment with 
ANP completely compensates this inflammatory action, causing a decrease in NF-κB binding activity 
during LPS-induced sepsis. Therefore, we presumed that ANP mediates its anti-inflammatory effects via 
the NF-κB pathway and subsequently concentrated on studying further processes involved in NF-κB 
activation. 
Dimerization of the p50 and p65 subunit is essential for activation of NF-κB. The p50 subunit lacks the 
transactivating domain which enables NF-κB to activate gene transcription (Adrie,C. et al., 2000, 
Blackwell,T.S. et al., 1997a). Consequently, homodimers of p50 cause NF-κB dysfunction in vitro 
(Viatour,P. et al., 2005, Ziegler-Heitbrock,H.W. et al., 1994). The p65 subunit, however, which contains a 
transactivation domain at the C-terminal end, is crucial for transcriptional actions of NF-κB. Under normal 
conditions, NF-κB is present in the cytoplasm in complex with its inhibitor IκBα (Annane,D. et al., 2005a). 
After stimulation, for example by binding of LPS to its receptor, the transcription factor translocates into 
the nucleus in order to bind to specific DNA recognition sites (Annane,D. et al., 2005d). 
In vitro ANP has been demonstrated to decrease TNF-α-induced translocation of p65 into the nucleus in 
HUVECs (Kiemer,A.K. et al., 2002s). Furthermore, pretreatment of isolated rat livers with ANP before IR 
caused markedly reduced protein levels of p50 and p65 in nuclear extracts of liver tissue after reperfusion 
(Kiemer,A.K. et al., 2000i). Such capture of NF-κB in the cytosol has been described to correlate with 
protective anti-inflammatory effects of peroxisome proliferator-activated receptor-gamma (PPR-gamma) 
activators in autoimmune myocarditis as well as with cardioprotective properties of [N-(3,5-bis-
trifluoromethyl-phenyl)-5-chloro-2-hydroxy-benzamide] (IMD-0354), an inhibitor of NF-κB activation 
(Onai,Y. et al., 2004a, Yuan,Z. et al., 2005). 
In our model of endotoxemia translocation of p65 into nuclei was observed in kidney cells of septic mice. 
Interestingly, ANP caused an inhibition of LPS-induced translocation, thus retaining the NF-κB complex in 
the cytosol. Our data therefore demonstrate anti-inflammatory effects of ANP during endotoxemia by 
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means of reduced translocation of the p65 subunit into the nucleus causing decreased NF-κB binding 
activity in vivo and we were now interested in mechanisms involved in this inhibition of NF-κB activity. 
 
 
5.2.3.1 Decreased phosphorylation of IκBα by ANP 
 
IκBα is the best characterized member of the IκB family. As demonstrated in studies with IκBα knockout 
mice, this protein plays a pivotal role in limiting NF-κB activation (Beg,A.A. et al., 1995a, Klement,J.F. et 
al., 1996b). Regulation of NF-κB transcriptional activity is facilitated by reversible binding of IκBα to the 
NF-κB complex, but the suppositions for NF-κB separation, translocation, and subsequent activation have 
been discussed intensively. On the one hand, Henkel et al. represent the opinion that the activation of 
NF-κB depends exclusively on a previous degradation of IκBα, whereas phosphorylation of the inhibitor is 
not mandatory (Henkel,T. et al., 1993). On the other hand, Beg et al. and Gosh et al. clearly demonstrate 
the dependence of NF-κB activation on a previous phosphorylation of its inhibitor (Beg,A.A. et al., 1993, 
Ghosh,S. et al., 1990). They show that IκBα has to be phosphorylated before it becomes separated from 
the NF-κB complex and immediately degraded, whereas free NF-κB translocates into the nucleus, 
subsequently activating further signaling cascades (for review see (Karin,M. et al., 2000). The crucial role 
of IκBα phosphorylation has also been described for LPS-induced NF-κB activation in vitro and in vivo 
(Chen,L.F. et al., 2004c, Chen,L.F. et al., 2004a, Guha,M. et al., 2001). 
In TNF-α-stimulated HUVECs treatment with ANP induced the expression of IκBα (Kiemer,A.K. et al., 
2002r). In contrast, in a model of IR in the isolated rat liver, Kiemer et al. did not see any influence of ANP 
on IκBα levels although NF-κB activity in ANP-treated livers was decreased, therefore suggesting NF-κB 
activation to be independent of IκB-α in this experimental setting (Kiemer,A.K. et al., 2000h). Onai et al. 
suggested the inhibition of IκBα phosphorylation by IMD-0354 (N-(3,5-Bis-trifluoromethyl-phenyl)-5-
chloro-2-hydroxy-benzamide) to be causally involved in the protection of rat hearts from myocardial IRI 
(Onai,Y. et al., 2004b). Furthermore, the results of Lopez et al. point to anti-inflammatory and therefore 
protective properties of an inhibition of phosphorylation and degradation of IκBα with respect to 
glomerulonephritis (Lopez-Franco,O. et al., 2002b). In LPS-treated cultured mesangial cells and 
monocytes the anti-inflammatory substances parthenolide and gliotoxin inhibit the phosphorylation and 
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degradation of IκBα. Additionally, in an in vivo model of experimental glomerulonephritis in rats these 
substances prevent renal lesions, proteinuria, and monocyte infiltration suggesting a crucial role for IκBα 
during inflammatory processes in the kidney (Lopez-Franco,O. et al., 2002c). Moreover, Tashiro et al. 
showed that an inhibition of NF-κB by stabilization of IκBα leads to attenuation of renal fibrosis in rats 
(Tashiro,K. et al., 2003). Therefore, we aimed to investigate the role of IκBα in our model of endotoxemia 
and the influence of ANP on this NF-κB inhibitor in the kidney. 
Our data show a strong phosphorylation of IκBα in kidneys of LPS-treated animals paralleled by 
decreased levels of IκBα pointing at a fast degradation of the inhibitor after phosphorylation. Interestingly, 
ANP causes a reduction in IκBα phosphorylation and therefore reduced degradation of the inhibitor in the 
kidney. Therefore we suggest that ANP prevents translocation and activation of NF-κB by maintaining 
IκBα in its non-phosphorylated state thus preventing inflammatory processes during sepsis in mice. 
With respect to second messengers involved in ANP-mediated effects the cyclic nucleotide cGMP (3´,5´-
cyclic guanosine monophosphate) has been shown to play a crucial role. Protective and anti-inflammatory 
properties of ANP such as prevention of IRI in isolated perfused rat livers (Gerbes,A.L. et al., 1998a, 
Kiemer,A.K. et al., 2000g) , as well as the inhibition of macrophages activation by ANP (Kiemer,A.K. et 
al., 1997a, Kiemer,A.K. et al., 2000f) were shown to be mediated via cGMP. In renal diseases the 
angiotensin II type 2 receptor (AT2-R) was demonstrated to exhibit protective effects via increased 
production of cGMP in the kidney (Matsubara,H., 1998). Moreover, an augmented renal cGMP production 
has been shown to contribute to protection of the kidney in chronic nephritis in rats (Uhlenius,N. et al., 
2002). The beneficial properties of ANP with regard to nephrotoxicity of immunosuppressive agents and 
antibiotics were also attributed to cGMP as the pivotal second messenger: Polte et al. observed in 
cultured proximal tubular cells (LLC-PK1 cells) that the cGMP analogue 8-bromo-cGMP mimics the 
cytoprotective effects of ANP and prevents cyclosporine A-dependent nephrotoxicity (Polte,T. et al., 
2002). Even more importantly, the results of Murakami et al. evidence that application of an adenovirus 
carrying the human ANP gene protects rats from gentamycine-induced renal failure, with cGMP levels 
being significantly increased in animals which received the ANP gene (Murakami,H. et al., 1999). As 
these findings suggest an involvement of cGMP in protective actions of ANP, we hypothesize that this 
second messenger might play a role in ANP-mediated ant-inflammatory properties in vivo. 
Regarding therapeutic potentials of ANP, pretreatment with this peptide might be a prophylactic strategy 
in treatment of patients at risk preventing the onset of inflammatory processes which cause the 
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progression of endotoxemia. However, intense research on further properties of ANP during sepsis in 
other organs and the elucidation of the involved signaling mechanism is required before final conclusions 
can be made about the therapeutic potential of ANP in sepsis. 
 
 
 
6. Summary  
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The Atrial Natriuretic Peptide (ANP) has recently been shown to possess cytoprotective potential in a 
variety of experimental settings. Most of the underlying signaling pathways however, remain to be 
clarified. 
In the model of IRI in the isolated perfused rat liver we could show that ANP preconditioning affects 
hepatic cytoskeletal structures. In detail, via activation of p38 MAPK and subsequently phosphorylation of 
Hsp27 ANP treatment of livers leads to enhanced cytoskeletal F-actin content. 
In the in vivo setting of liver-transplantation anti-apoptotic effects of ANP could characterized. ANP 
preconditioning leads to activation of the PI3-K/Akt pathway and inactivation of the pro-apoptotic protein 
Bad. 
In a murine model of sepsis ANP pretreatment was shown to increase survival of the animals, which was 
paralleled by reduced serum TNF-α level.  
Focussing on the kidney, ANP treatment results in inhibition of IκBα degradation. 
In summary, this work contributes to a better understanding of the mechanism of action underlying the 
anti-inflammatory and cytoprotective effects of the Atrial Natriuretic Peptide. 
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8.1 ABBREVIATIONS 
 
A     Ampère 
ADF     Actin depolymerizing factor 
ALT     alanine transferase 
ANP     Atrial Natriuretic Peptide 
AP-1     Activator protein-1 
AST     aspartate transferase 
ATP     Adenosine-5`-triphosphate 
BNP     Brain Natriuretic Peptide 
Bp     Basepair 
8-Br-cGMP    8-Bromo-3`,5`-cyclic monophosphate 
BSA     Bovine serum albumine 
°C     Degree Celsius 
cAMP     Cyclic Adenosine-5`-monophosphate 
cGMP     Cyclic Guanosine-5`-monophosphate 
Ci     Curie (1 Ci=3.7x107 Bequerel) 
CNP     C-type Natriuretic Peptide 
Co     Control 
cpm     Counts per minute 
Da     Dalton 
DMSO     Dimethylsulfoxide 
DNA     Desoxyribonucleic acid 
DTT     Dithiothreitol 
EC     Endothelial cell 
EDTA     Ethylenediaminetetraacetic acid 
EGTA     Ethyleneglycol-bis(aminoethylether)-tetraacetic acid 
EMSA     Electrophoretic mobility shift assay 
Erk     Extracellular-regulated kinase 
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EtOH     Ethanol 
G     Gram 
GDP     Guanosine-5`-diphosphate 
GTP     Guanosine-5`-triphosphate 
H     Hour 
HEPES     N-(2-hydroxyethyl)piperazine 
HRP     Horseradish peroxidase 
HUVEC    Human umbilical vein endothelial cell 
IκBα     Inhibitor of κB α 
IR     Ischemia/Reperfusion 
IRI     Ischemia reperfusion injury 
JNK     c-Jun N-terminal kinase 
KC     Kupffer cell 
kDa     Kilo Dalton 
l     Liter 
LDH     Lactate dehydrogenase 
LPS     Lipopolysaccharide 
m     Milli (10-3) 
M     Molar 
µ     Micro (10-6) 
MAPK     Mitogen-activated kinase 
MCP-1     Monocyte chemoattractant protein-1 
MeOH     Methanol 
min     Minute 
MKP     Mitogen-activated kinase phosphatase 
MPT     Mitochondrial permeability transition 
mRNA     Messenger ribonucleic acid 
n     Nano (10-9) 
NF-κB     Nuclear factor-κB 
NO     Nitric oxide 
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NP     Natriuretic Peptide 
NPR     Natriuretic Peptide receptor 
PAA     Polyacrylamide 
PAGE     Polyacrylamide-gel electrophoresis 
PBS     Phosphate buffered saline 
PI3-K     Phosphatidylinositol-3 kinase 
PIP3     Phosphatidylinositol-3,4,5-triphosphate 
PKA     cAMP-dependent protein kinase 
PKC     Protein kinase C 
PKG     cGMP-dependent protein kinase 
PMSF     Phenylmethylsulfonylfluoride 
RNA     Ribonucleic acid 
ROS     Reactive oxygen species 
rpm     Rounds per minute 
RT     Room temperature 
SDS     Sodium dodecyl sulfate 
sec     Second 
SEM     Standard error of mean 
TBS-T     Phosphate buffered saline solution with Tween 
TEMED    Tetramethylethylenediamine 
TNF-α     Tumor necrosis factor alpha 
Tris     Tris-hydromethyl-aminomethan 
U     Unit 
V     Volt 
W     Watt 
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8.2 ALPHABETICAL LIST OF COMPANIES 
 
Alexis Biochemicals   Grünberg, Germany 
AGFA     Cologne, Germany 
Amersham    Braunschweig, Germany 
Bachem    Heidelberg, Germany 
BD Biosciences   Heidelberg, Germany 
Beckman Instruments   Munich, Germany 
Biomol     Hamburg, Germany 
Bio-Rad Laboratories   Munich, Germany 
Biosource    Nivella, Belgium 
Biozol     Eching, Germany 
Boehringer    Mannheim, Germany 
Braun     Melsungen, Germany 
Calbiochem    Schwalbach, Germany 
Canberra-Packard   Dreieich, Germany 
Cell signaling/NEB   Frankfurt/Main, Germany 
Charles River GmbH   Sulzfeld, Germany 
Dianova    Hamburg, Germany 
Eppendorf    Maintal, Germany 
Fuji     Düsseldorf, Germany 
Greiner     Frickenhausen, Germany 
Heraeus    Hanau, Germany 
Kodak     Rochester, USA 
Leinco/Biotrend    Cologne, Germany 
Merck-Eurolab    Munich, Germany 
Millipore    Eschborn, Germany 
Molecular Probes/Invitrogen  Karlsruhe, Germany 
NEN     Cologne, Germany 
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Olympus Optical   Hamburg, Germany 
Perkin-Elmer    Rodgau-Jügesheim, Germany 
Peske     Aindling-Pichl, Germany 
Pharmacia Biotech   Heidelberg, Germany 
Pierce     Rockford, USA 
Roche Diagnostics   Mannheim, Germany 
Roth     Karlsruhe, Germany 
Santa Cruz    Heidelberg, Germany 
Siemens    Erlangen, Germany 
Sigma-Aldrich    Taufkirchen, Germany 
Ssniff     Soest, Germany 
Stressgen    San Diego, USA 
Upstate/Biomol    Hamburg, Germany 
Zeiss     Oberkochen, Germany 
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